CA2607387A1 - Access and closure device and method - Google Patents
Access and closure device and method Download PDFInfo
- Publication number
- CA2607387A1 CA2607387A1 CA 2607387 CA2607387A CA2607387A1 CA 2607387 A1 CA2607387 A1 CA 2607387A1 CA 2607387 CA2607387 CA 2607387 CA 2607387 A CA2607387 A CA 2607387A CA 2607387 A1 CA2607387 A1 CA 2607387A1
- Authority
- CA
- Canada
- Prior art keywords
- lumen
- introduction
- guide
- anchor
- arteriotomy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3209—Incision instruments
- A61B17/32093—Incision instruments for skin incisions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/065—Guide needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3415—Trocars; Puncturing needles for introducing tubes or catheters, e.g. gastrostomy tubes, drain catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/0042—Surgical instruments, devices or methods, e.g. tourniquets with special provisions for gripping
- A61B2017/00455—Orientation indicators, e.g. recess on the handle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00637—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/0065—Type of implements the implement being an adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00672—Locating means therefor, e.g. bleed back lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00676—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect promotion of self-sealing of the puncture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/0293—Catheter, guide wire or the like with means for holding, centering, anchoring or frictionally engaging the device within an artificial lumen, e.g. tube
Abstract
Devices and methods for accessing and closing vascular sites are disclosed.
Self-sealing closure devices and methods are disclosed. A device that can make both steeply sloping and flat access paths into a vascular lumen is disclosed.
The device can also form arteriotomies with sections cleaved between a vessel's intima and adventitia. Methods for using the device are also disclosed.
Self-sealing closure devices and methods are disclosed. A device that can make both steeply sloping and flat access paths into a vascular lumen is disclosed.
The device can also form arteriotomies with sections cleaved between a vessel's intima and adventitia. Methods for using the device are also disclosed.
Description
ACCESS AND CLOSURE DEVICE AND METHOD
D. Bruce Modesitt CROSS-REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit under 35 U.S.C. 119(e) of U.S.
Provisional Application 60/680,388 filed May 12, 2005, the content of which is incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of the Invention [0002] The present invention relates to the field of accessing a biological lumen and closing the access port thereby created.
2. Description of the Related Art [0003] A number of diagnostic and interventional vascular procedures are now performed translumenally, where a catheter is introduced to the vascular system at a convenient access location - such as the femoral, brachial, or subclavian arteries - and guided through the vascular system to a target location to perform therapy or diagnosis. VWhen vascular access is no longer required, the catheter and other vascular access devices must be removed from the vascular entrance and bleeding at the puncture site must be stopped.
D. Bruce Modesitt CROSS-REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit under 35 U.S.C. 119(e) of U.S.
Provisional Application 60/680,388 filed May 12, 2005, the content of which is incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of the Invention [0002] The present invention relates to the field of accessing a biological lumen and closing the access port thereby created.
2. Description of the Related Art [0003] A number of diagnostic and interventional vascular procedures are now performed translumenally, where a catheter is introduced to the vascular system at a convenient access location - such as the femoral, brachial, or subclavian arteries - and guided through the vascular system to a target location to perform therapy or diagnosis. VWhen vascular access is no longer required, the catheter and other vascular access devices must be removed from the vascular entrance and bleeding at the puncture site must be stopped.
[0004] One common approach for providing hemostasis is to apply external force near and upstream from the puncture site, typically by manual compression.
This method is time-consuming, frequently requiring one-half hour or more of I compression before hemostasis. This procedure is uncomfortable for the patient and 2 frequently requires administering analgesics. Excessive pressure can also present the 3 risk of total occlusion of the blood vessel, resulting in ischemia and/or thrombosis.
4 [0005] After hemostasis is achieved by manual compression, the patient is required to remain recumbent for six to eighteen hours under observation to assure 6 continued hemostasis. During this time bleeding from the vascular access wound can 7 restart, potentially resulting in major complications. These complications may require 8 blood transfusion and/or surgical intervention.
9 [0006] Bioabsorbable fasteners have also been used to stop bleeding.
Generally, these approaches rely on the placement of a thrombogenic and bioabsorbable material, 11 such as collagen, at the superficial arterial wall over the puncture site.
This method 12 generally presents difficulty locating the interface of the overlying tissue and the 13 adventitial surface of the blood vessel. Implanting the fastener too far from the 14 desired location can result in failure to provide hemostasis. If, however, the fastener intrudes into the vascular lumen, thrombus can form on the fastener. Thrombus can 16 embolize downstream and/or block normal blood flow at the thrombus site.
17 Implanted fasteners can also cause infection and auto-immune reactions/rejections of 18 the implant.
19 [0007] Suturing methods are also used to provide hemostasis after vascular access. The suture-applying device is introduced through the tissue tract with a distal 21 end of the device located at the vascular puncture. Needles in the device draw suture 22 through the blood vessel wall on opposite sides of the punctures, and the suture is 23 secured directly over the adventitial surface of the blood vessel wall to close the 24 vascular access wound.
tuuursl 1 o ne successful, suturing methods need to be performed with a precise 2 control. The needles need to be properly directed through the blood vessel wall so 3 that the suture is well anchored in tissue to provide for tight closure.
Suturing 4 methods also require additional steps for the surgeon.
[0009] Due to the deficiencies of the above methods and devices, a need exists for 6 a more reliable vascular closure method and device. There also exists a need for a 7 vascular closure device and method that is self-sealing and secure. There also exists a 8 need for a vascular closure device and method requiring no or few extra steps to close 9 the vascular site.
12 [0010] A method for accessing a biological lumen having a lumen wall and 13 surrounding tissue is disclosed. The method includes forming a path between the 14 lumen wall and the surrounding tissue. The method further includes extending the path through the lumen wall. The method also includes opening the path to the 16 lumen.
17. [0011] The method of forming the path can include inserting a device between the 18 lumen wall and the surrounding tissue. Extending the path can include inserting the 19 device through the lumen wall. Opening the path can include inserting the device into the lumen. The method can include. delivering a filler into the path.
21 [0012] The method can include filling the path. Filling the path can include 22 delivering a-filler into the path. The filler can have a solid-setting liquid. The filler 23 can have an epoxy.
24 [0013] The method can include applying pressure to the path. Applying pressure to the path can include delivering filler adjacent to the path. Delivering filler adjacent 1 to the path can include delivering filler between the lumen wall and the surrounding 2 tissue. Delivering filler can include delivering filler in the lumen wall.
Delivering 3 filler can include delivering filler in the surrounding tissue.
4 [0014] Also disclosed is a method for forming an arteriotomy in a lumen having a lumen wall and surrounding tissue. The method includes translating a device 6 substantially between the lumen wall and the surrounding tissue. The method further 7 includes turning the device toward the lumen. The method also includes translating 8 the device through the lumen wall. The method also includes removing the device 9 from the lumen wall.
[0015] The surrounding tissue can have adventitia. Turning can include 11 relaxation of a pre-formed configuration in the device.
12 [0016] The method can also include translating a guide through the device.
13 Translating a guide can include translating the guide into the lumen. The method can 14 also include translating a guide into the lumen. Translating a guide can include translating the guide through the device.
16 [0017] An access device for accessing a biological lumen is disclosed. The 17 device has an introduction device having a relaxed configuration. The relaxed 18 configurationhas a first flat section, a first bend at an end of the first flat section, and 19 ' a first slope extending at a first end from the first bend. The introduction device is configured to be translated with respect to the access device.
21 [0018] The-relaxed configuration of the introduction device can have. a second 22 bend at a second end of the first slope, a second. flat section extending at a first end 23 from the second bend, a third bend at a second end of the second flat section, and a 24 second slope extending from the third bend. The access device can have a delivery guide. The delivery guide can be configured to deliver the introduction device.
1 [0019] The access device can have an anchor. The anchor can extend from the 2 delivery guide. The anchor can be configured to stabilize the access device with 3 respect to the lumen.
4 [0020] A device for accessing a biological lumen is disclosed. The biological lumen has a lumen wall having a longitudinal lumen wall axis. The device has an 6 elongated member that has a longitudinal member axis. The member is configured to 7 access the lumen at a first angle.
[0021] Figure 1 is an embodiment of a method of using the arteriotomy device in 11 a cross-section of a lumen.
12 [0022] Figures 2 through 5 illustrate a method of using the arteriotomy device in a 13 cross-section of a lumen.
14 [0023] Figure 6 illustrates a portion of an arteriotomized lumen.
[0024] Figures 7 through 11 illustrate various embodiments of section A-A of 16 Figure 6.
17 [0025] Figure 12 illustrates an embodiment of the arteriotomy device in a first 18 configuration.
19 [00261 Figure 13 is a close-up view of an embodiment of section B of Figure 12.
[0027] Figure 14 illustrates an embodiment of the arteriotomy device of Figure 21 in a second configuration.
22 [0028] Figure 15 is a close-up view of an embodiment of section C of Figure 14.
23 [0029] Figure 16 illustrates an embodiment of the arteriotomy device of Figure 12 24 in a third configuration.
[0030] Figure 17 is a close-up view of an embodiment of section D of Figure 16.
This method is time-consuming, frequently requiring one-half hour or more of I compression before hemostasis. This procedure is uncomfortable for the patient and 2 frequently requires administering analgesics. Excessive pressure can also present the 3 risk of total occlusion of the blood vessel, resulting in ischemia and/or thrombosis.
4 [0005] After hemostasis is achieved by manual compression, the patient is required to remain recumbent for six to eighteen hours under observation to assure 6 continued hemostasis. During this time bleeding from the vascular access wound can 7 restart, potentially resulting in major complications. These complications may require 8 blood transfusion and/or surgical intervention.
9 [0006] Bioabsorbable fasteners have also been used to stop bleeding.
Generally, these approaches rely on the placement of a thrombogenic and bioabsorbable material, 11 such as collagen, at the superficial arterial wall over the puncture site.
This method 12 generally presents difficulty locating the interface of the overlying tissue and the 13 adventitial surface of the blood vessel. Implanting the fastener too far from the 14 desired location can result in failure to provide hemostasis. If, however, the fastener intrudes into the vascular lumen, thrombus can form on the fastener. Thrombus can 16 embolize downstream and/or block normal blood flow at the thrombus site.
17 Implanted fasteners can also cause infection and auto-immune reactions/rejections of 18 the implant.
19 [0007] Suturing methods are also used to provide hemostasis after vascular access. The suture-applying device is introduced through the tissue tract with a distal 21 end of the device located at the vascular puncture. Needles in the device draw suture 22 through the blood vessel wall on opposite sides of the punctures, and the suture is 23 secured directly over the adventitial surface of the blood vessel wall to close the 24 vascular access wound.
tuuursl 1 o ne successful, suturing methods need to be performed with a precise 2 control. The needles need to be properly directed through the blood vessel wall so 3 that the suture is well anchored in tissue to provide for tight closure.
Suturing 4 methods also require additional steps for the surgeon.
[0009] Due to the deficiencies of the above methods and devices, a need exists for 6 a more reliable vascular closure method and device. There also exists a need for a 7 vascular closure device and method that is self-sealing and secure. There also exists a 8 need for a vascular closure device and method requiring no or few extra steps to close 9 the vascular site.
12 [0010] A method for accessing a biological lumen having a lumen wall and 13 surrounding tissue is disclosed. The method includes forming a path between the 14 lumen wall and the surrounding tissue. The method further includes extending the path through the lumen wall. The method also includes opening the path to the 16 lumen.
17. [0011] The method of forming the path can include inserting a device between the 18 lumen wall and the surrounding tissue. Extending the path can include inserting the 19 device through the lumen wall. Opening the path can include inserting the device into the lumen. The method can include. delivering a filler into the path.
21 [0012] The method can include filling the path. Filling the path can include 22 delivering a-filler into the path. The filler can have a solid-setting liquid. The filler 23 can have an epoxy.
24 [0013] The method can include applying pressure to the path. Applying pressure to the path can include delivering filler adjacent to the path. Delivering filler adjacent 1 to the path can include delivering filler between the lumen wall and the surrounding 2 tissue. Delivering filler can include delivering filler in the lumen wall.
Delivering 3 filler can include delivering filler in the surrounding tissue.
4 [0014] Also disclosed is a method for forming an arteriotomy in a lumen having a lumen wall and surrounding tissue. The method includes translating a device 6 substantially between the lumen wall and the surrounding tissue. The method further 7 includes turning the device toward the lumen. The method also includes translating 8 the device through the lumen wall. The method also includes removing the device 9 from the lumen wall.
[0015] The surrounding tissue can have adventitia. Turning can include 11 relaxation of a pre-formed configuration in the device.
12 [0016] The method can also include translating a guide through the device.
13 Translating a guide can include translating the guide into the lumen. The method can 14 also include translating a guide into the lumen. Translating a guide can include translating the guide through the device.
16 [0017] An access device for accessing a biological lumen is disclosed. The 17 device has an introduction device having a relaxed configuration. The relaxed 18 configurationhas a first flat section, a first bend at an end of the first flat section, and 19 ' a first slope extending at a first end from the first bend. The introduction device is configured to be translated with respect to the access device.
21 [0018] The-relaxed configuration of the introduction device can have. a second 22 bend at a second end of the first slope, a second. flat section extending at a first end 23 from the second bend, a third bend at a second end of the second flat section, and a 24 second slope extending from the third bend. The access device can have a delivery guide. The delivery guide can be configured to deliver the introduction device.
1 [0019] The access device can have an anchor. The anchor can extend from the 2 delivery guide. The anchor can be configured to stabilize the access device with 3 respect to the lumen.
4 [0020] A device for accessing a biological lumen is disclosed. The biological lumen has a lumen wall having a longitudinal lumen wall axis. The device has an 6 elongated member that has a longitudinal member axis. The member is configured to 7 access the lumen at a first angle.
[0021] Figure 1 is an embodiment of a method of using the arteriotomy device in 11 a cross-section of a lumen.
12 [0022] Figures 2 through 5 illustrate a method of using the arteriotomy device in a 13 cross-section of a lumen.
14 [0023] Figure 6 illustrates a portion of an arteriotomized lumen.
[0024] Figures 7 through 11 illustrate various embodiments of section A-A of 16 Figure 6.
17 [0025] Figure 12 illustrates an embodiment of the arteriotomy device in a first 18 configuration.
19 [00261 Figure 13 is a close-up view of an embodiment of section B of Figure 12.
[0027] Figure 14 illustrates an embodiment of the arteriotomy device of Figure 21 in a second configuration.
22 [0028] Figure 15 is a close-up view of an embodiment of section C of Figure 14.
23 [0029] Figure 16 illustrates an embodiment of the arteriotomy device of Figure 12 24 in a third configuration.
[0030] Figure 17 is a close-up view of an embodiment of section D of Figure 16.
1 [0031] Figure 18 illustrates an embodiment of the arteriotomy device of Figure 12 2 in a fourth configuration.
3 [0032] Figure 19 is a close-up view of an embodiment of section E of Figure 18.
4 [0033] Figure 20 illustrates an embodiment of the arteriotomy device of Figure 12 in a fourth configuration.
6 [0034] Figures 21 and 22 are close-up views of various embodiments of section F
3 [0032] Figure 19 is a close-up view of an embodiment of section E of Figure 18.
4 [0033] Figure 20 illustrates an embodiment of the arteriotomy device of Figure 12 in a fourth configuration.
6 [0034] Figures 21 and 22 are close-up views of various embodiments of section F
7 of Figure 20.
8 [0035] Figure 23 illustrates an embodiment of the arteriotomy device.
9 [0036] Figure 24 illustrates an embodiment of the arteriotomy device of Figure 12 in a fifth configuration.
11 [0037] Figure 25 is a close-up view of an embodiment of section G of Figare 24.
12 [0038] Figure 26 illustrates an embodiment of the arteriotomy device.
13 [0039] Figure 27 is a close-up view of an embodiment of section H of Figure 26.
14 [0040] Figures 28 through 32 illustrate various embodiments of cross-section I-1 of Figure 27.
16 [0041] Figures 33 and 34 are a perspective and side view, respectively, of an 17 embodiment of section H of Figure 26.
18 [0042] Figure 35 illustrates an embodiment of a method of using the arteriotomy 19 device in a cross-section of a lumen.
[0043] Figure 36 is a close-up view of an embodiment. of section J of Figure 35.
21 [0044] .Figure 37 illustrates an embodiment of a method of using an embodiment 22 of the arteriotomy device of Figure 35 in a cross-section of a lumen.
23 [0045] Tigure 38 is a close-up view of an embodiment of section K of Figure 37.
24 [0046] Figures 39 and 40 illustrate various methods of using the arteriotomy device.
i [uu41] r'igures 41 and 42 illustrate sectional views of an embodiment of the 2 delivery guide.
3 [0048] Figures 43 through 48 illustrate various embodiments of the introduction 4 device.
[0049] Figures 49 and 50 are various embodiments of cross-section K-K of Figure 6 48.
7 [0050] Figures 51 through 53 illustrate various embodiments of the introduction 8 device.
9 [0051] Figures 54 and 55 illustrate various embodiments of the introduction device in relaxed configurations.
12 [0052] U.S. Patent Application No. 10/844,247, filed 12 May 2004, is 13 incorporated by reference herein in its entirety. Aspects, characteristics, components 14 or complete embodiments of devices and methods disclosed therein can be used with anything disclosed herein.
16 [0053] Figures 1 through 6 illustrate embodiments of an arteriotomy device 2, and 17 methods for accessing (e.g., percutaneously) a biological lumen 4 and deploying an 18 introduction device 6 that can have one or more pre-formed bends. The biological 19 lumen 4 can be surrounded by a lumen wall 8 (e.g., intima and/or media).
The lumen wa118 can be surrounded by surrounding tissue 10 (e.g., media and/or adventitia).
21 [0054] The arteriotomy device 2 can have a delivery guide 12. The delivery guide 22 12 can be slidably attached to an anchor 14. The anchor 14 can be rigid, flexible or 23 combinations thereof. The anchor 14 can be resilient, deformable or combinations 24 thereof. The anchor 14 can be retractable and extendable from the delivery guide 12.
The anchor 14 can have a guide eye sheath or an attachable guidewire. The anchor 14 1 can have an integral, or multiple separate and fixedly attached, wound wire.
The 2 anchor 14 can have a wire coating, for example a lubricious coating and/or a coating 3 made from urethane 4 [0055] The anchor 14 can have an anchor longitudinal axis 16. The introduction device can have an introduction longitudinal axis 18. The intersection of the anchor 6 longitudinal axis 16 and the introduction longitudinal axis 18 can be an introduction 7 angle 20. The anchor 14 can be inserted into the biological lumen 4 using a Seldinger 8 technique, modified Seldinger technique, or other method known to one having 9 ordinary skill in the art.
[0056] The arteriotomy device 2 can be configured to deliver the introduction 11 device at the introduction angle 20. The introduction device 6 can have an 12 introduction longitudinal axis. The introduction angle 20 can be the intersection of 13 the introduction longitudinal axis 18 and the anchor longitudinal axis 16.
The 14 introduction angle 20 can have an absolute value from about 0 to about 30 , more narrowly from about 0 to about 19 , yet more narrowly from about 0 to about 15 , 16 yet more narrowly from about 5 to about 10 , for example about 10 .
17 [0057] Any or all elements of the arteriotomy device 2 or other devices or 18 apparatuses described herein can be made from, for example, a single or multiple 19 stainless steel alloys, nickel titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY from Elgin Specialty Metals, Elgin, IL; CONICHROME from 21 Carpenter Metals Corp., Wyomissing, PA), molybdenum alloys (e.g., molybdenum 22 TZM alloy, for example as disclosed in International Pub. No. WO 03/082363 A2, 23 published 9 October 2003, which is herein incorporated by reference in its entirety), 24 tungsten-rhenium alloys, for example, as disclosed.in International Pub.
No. WO
03/082363, polymers such as polyester (e.g., DACRON from E. I. Du Pont de 1 Nemours and Company, Wilmington, DE), carbon fiber composites (e.g., carbon fiber 2 nylon composite, such as carbon fiber reinforced nylon 66), polypropylene, 3 polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polyether ether ketone 4 (PEEK), nylon, polyether-block co-polyamide polymers (e.g., PEBAX from ATOFINA, Paris, France), aliphatic polyether polyurethanes (e.g., TECOFLEX
6 from Thermedics Polymer Products, Wilmington, MA), polyvinyl chloride (PVC), 7 polyurethane, thermoplastic, fluorinated ethylene propylene (FEP), absorbable or 8 resorbable polymers such as polyglycolic acid (PGA), polylactic acid (PLA), 9 polydioxanone, and pseudo-polyamino tyrosine-based acids, extruded collagen, silicone, zinc, echogenic, radioactive, radiopaque materials or combinations thereof.
11 Examples of radiopaque materials are barium sulfate, zinc oxide, titanium, stainless 12 steel, nickel-titanium alloys, tantaluin and gold.
13 [0058] Any or all elements of the arteriotomy device 2, including supplemental 14 closure devices, such as filler, or other devices or apparatuses described herein can be or have a matrix for cell ingrowth or used with a fabric, for example a covering (not 16 shown) that acts as a matrix for cell ingrowth. The matrix and/or fabric can be, for 17 example, polyester (e.g., DACRON from E. I. du Pont de Nemours and Company, 18 Wilmington, DE), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or 19 combinations thereof.
[0059] The elements of the arteriotomy device 2 and/or the filler and/or the fabric 21 can be filled and/or coated with an agent delivery matrix known to one having 22 ordinary skill in the art and/or a therapeutic and/or diagnostic agent. The agents 23 within these matrices can include radioactive materials; radiopaque materials;
24 cytogenic agents; cytotoxic agents; cytostatic agents; thrombogenic agents, for example polyurethane, cellulose acetate polymer mixed with bismuth trioxide, and 1 ethylene vinyl alcohol; lubricious, hydrophilic materials; phosphor cholene;
anti-2 inflammatory agents, for example non-steroidal anti-inflanunatories (NSAIDs) such 3 as cyclooxygenase-1 (COX-1) inhibitors (e.g., acetylsalicylic acid, for example 4 ASPIRINO from Bayer AG, Leverkusen, Germany; ibuprofen, for example ADVILO
from Wyeth, Collegeville, PA; indomethacin; mefenamic acid), COX-2 inhibitors 6 (e.g., VIOXXO from Merck & Co., Inc., Whitehouse Station, NJ; CELEBREXO
7 from Pharmacia Corp., Peapack, NJ; COX-1 inhibitors); immunosuppressive agents, 8 for example Sirolimus (RAPAMUNEO, from Wyeth, , Collegeville, PA), or matrix 9 metalloproteinase (MMP) inhibitors (e.g., tetracycline and tetracycline derivatives) that act early within the pathways of an inflammatory response. Examples of other 11 agents are provided in Walton et al, Inhibition of Prostoglandin E2 Synthesis in 12 Abdominal Aortic Aneurysms, Circulation, July 6, 1999, 48-54; Tambiah et al, 13 Provocation of Experimental Aortic Inflammation Mediators and Chlamydia 14 Pneumoniae, Brit. J. Surgef-y 88 (7), 935-940; Franklin et al, Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis, Brit.
J.
16 Surgery 86 (6), 771-775; Xu et al, Spl Increases Expression of Cyclooxygenase-2 in 17 Hypoxic Vascular Endothelium, J. Biological Chemistry 275 (32) 24583-24589;
and 18 Pyo et al, Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) 19 Suppresses Development of Experimental Abdominal Aortic Aneurysms, J.
Clinical Investigation 105 (11),1641-1649 which are all incorporated by reference in their 21 entireties.
22 [0060] The delivery guide 12 can be deployed through the surrounding tissue 23 and into the lumen wal18 and/or the lumen 4. As illustrated in Figures 45 and 46 of 24 U.S. Patent Application No. 10/844,247 for a toggle deployment device, the arteriotomy device 2 can have a pressure check port. The pressure check port can be 1 in fluid communication with a sensor or port on or near the handle of the arteriotomy 2 device 2, such as an external lumen where blood flow can be observed, for example 3 from flow from the end of an external tube or port and/or through a transparent or 4 translucent window. The pressure check port can facilitate deployment of the arteriotomy device 2 to a location where the pressure check port is introduced to 6 pressure, for example when the pressure check port enters the biological lumen 4.
7 The sensor or port on or near the handle of the arteriotomy device 2 will signal that 8 the pressure check port has been placed into the biological lumen 4 (e.g., by 9 displaying a small amount of blood flow). The pressure check port can be deployed into the biological lumen 4 and then withdrawn from the biological lumen 4 to the 11 point where the lumen wall 8 just stops the pressure in the pressure check port. An 12 entry wall retainer port can additionally perform the function as described herein for 13 the pressure check port.
11 [0037] Figure 25 is a close-up view of an embodiment of section G of Figare 24.
12 [0038] Figure 26 illustrates an embodiment of the arteriotomy device.
13 [0039] Figure 27 is a close-up view of an embodiment of section H of Figure 26.
14 [0040] Figures 28 through 32 illustrate various embodiments of cross-section I-1 of Figure 27.
16 [0041] Figures 33 and 34 are a perspective and side view, respectively, of an 17 embodiment of section H of Figure 26.
18 [0042] Figure 35 illustrates an embodiment of a method of using the arteriotomy 19 device in a cross-section of a lumen.
[0043] Figure 36 is a close-up view of an embodiment. of section J of Figure 35.
21 [0044] .Figure 37 illustrates an embodiment of a method of using an embodiment 22 of the arteriotomy device of Figure 35 in a cross-section of a lumen.
23 [0045] Tigure 38 is a close-up view of an embodiment of section K of Figure 37.
24 [0046] Figures 39 and 40 illustrate various methods of using the arteriotomy device.
i [uu41] r'igures 41 and 42 illustrate sectional views of an embodiment of the 2 delivery guide.
3 [0048] Figures 43 through 48 illustrate various embodiments of the introduction 4 device.
[0049] Figures 49 and 50 are various embodiments of cross-section K-K of Figure 6 48.
7 [0050] Figures 51 through 53 illustrate various embodiments of the introduction 8 device.
9 [0051] Figures 54 and 55 illustrate various embodiments of the introduction device in relaxed configurations.
12 [0052] U.S. Patent Application No. 10/844,247, filed 12 May 2004, is 13 incorporated by reference herein in its entirety. Aspects, characteristics, components 14 or complete embodiments of devices and methods disclosed therein can be used with anything disclosed herein.
16 [0053] Figures 1 through 6 illustrate embodiments of an arteriotomy device 2, and 17 methods for accessing (e.g., percutaneously) a biological lumen 4 and deploying an 18 introduction device 6 that can have one or more pre-formed bends. The biological 19 lumen 4 can be surrounded by a lumen wall 8 (e.g., intima and/or media).
The lumen wa118 can be surrounded by surrounding tissue 10 (e.g., media and/or adventitia).
21 [0054] The arteriotomy device 2 can have a delivery guide 12. The delivery guide 22 12 can be slidably attached to an anchor 14. The anchor 14 can be rigid, flexible or 23 combinations thereof. The anchor 14 can be resilient, deformable or combinations 24 thereof. The anchor 14 can be retractable and extendable from the delivery guide 12.
The anchor 14 can have a guide eye sheath or an attachable guidewire. The anchor 14 1 can have an integral, or multiple separate and fixedly attached, wound wire.
The 2 anchor 14 can have a wire coating, for example a lubricious coating and/or a coating 3 made from urethane 4 [0055] The anchor 14 can have an anchor longitudinal axis 16. The introduction device can have an introduction longitudinal axis 18. The intersection of the anchor 6 longitudinal axis 16 and the introduction longitudinal axis 18 can be an introduction 7 angle 20. The anchor 14 can be inserted into the biological lumen 4 using a Seldinger 8 technique, modified Seldinger technique, or other method known to one having 9 ordinary skill in the art.
[0056] The arteriotomy device 2 can be configured to deliver the introduction 11 device at the introduction angle 20. The introduction device 6 can have an 12 introduction longitudinal axis. The introduction angle 20 can be the intersection of 13 the introduction longitudinal axis 18 and the anchor longitudinal axis 16.
The 14 introduction angle 20 can have an absolute value from about 0 to about 30 , more narrowly from about 0 to about 19 , yet more narrowly from about 0 to about 15 , 16 yet more narrowly from about 5 to about 10 , for example about 10 .
17 [0057] Any or all elements of the arteriotomy device 2 or other devices or 18 apparatuses described herein can be made from, for example, a single or multiple 19 stainless steel alloys, nickel titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY from Elgin Specialty Metals, Elgin, IL; CONICHROME from 21 Carpenter Metals Corp., Wyomissing, PA), molybdenum alloys (e.g., molybdenum 22 TZM alloy, for example as disclosed in International Pub. No. WO 03/082363 A2, 23 published 9 October 2003, which is herein incorporated by reference in its entirety), 24 tungsten-rhenium alloys, for example, as disclosed.in International Pub.
No. WO
03/082363, polymers such as polyester (e.g., DACRON from E. I. Du Pont de 1 Nemours and Company, Wilmington, DE), carbon fiber composites (e.g., carbon fiber 2 nylon composite, such as carbon fiber reinforced nylon 66), polypropylene, 3 polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polyether ether ketone 4 (PEEK), nylon, polyether-block co-polyamide polymers (e.g., PEBAX from ATOFINA, Paris, France), aliphatic polyether polyurethanes (e.g., TECOFLEX
6 from Thermedics Polymer Products, Wilmington, MA), polyvinyl chloride (PVC), 7 polyurethane, thermoplastic, fluorinated ethylene propylene (FEP), absorbable or 8 resorbable polymers such as polyglycolic acid (PGA), polylactic acid (PLA), 9 polydioxanone, and pseudo-polyamino tyrosine-based acids, extruded collagen, silicone, zinc, echogenic, radioactive, radiopaque materials or combinations thereof.
11 Examples of radiopaque materials are barium sulfate, zinc oxide, titanium, stainless 12 steel, nickel-titanium alloys, tantaluin and gold.
13 [0058] Any or all elements of the arteriotomy device 2, including supplemental 14 closure devices, such as filler, or other devices or apparatuses described herein can be or have a matrix for cell ingrowth or used with a fabric, for example a covering (not 16 shown) that acts as a matrix for cell ingrowth. The matrix and/or fabric can be, for 17 example, polyester (e.g., DACRON from E. I. du Pont de Nemours and Company, 18 Wilmington, DE), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or 19 combinations thereof.
[0059] The elements of the arteriotomy device 2 and/or the filler and/or the fabric 21 can be filled and/or coated with an agent delivery matrix known to one having 22 ordinary skill in the art and/or a therapeutic and/or diagnostic agent. The agents 23 within these matrices can include radioactive materials; radiopaque materials;
24 cytogenic agents; cytotoxic agents; cytostatic agents; thrombogenic agents, for example polyurethane, cellulose acetate polymer mixed with bismuth trioxide, and 1 ethylene vinyl alcohol; lubricious, hydrophilic materials; phosphor cholene;
anti-2 inflammatory agents, for example non-steroidal anti-inflanunatories (NSAIDs) such 3 as cyclooxygenase-1 (COX-1) inhibitors (e.g., acetylsalicylic acid, for example 4 ASPIRINO from Bayer AG, Leverkusen, Germany; ibuprofen, for example ADVILO
from Wyeth, Collegeville, PA; indomethacin; mefenamic acid), COX-2 inhibitors 6 (e.g., VIOXXO from Merck & Co., Inc., Whitehouse Station, NJ; CELEBREXO
7 from Pharmacia Corp., Peapack, NJ; COX-1 inhibitors); immunosuppressive agents, 8 for example Sirolimus (RAPAMUNEO, from Wyeth, , Collegeville, PA), or matrix 9 metalloproteinase (MMP) inhibitors (e.g., tetracycline and tetracycline derivatives) that act early within the pathways of an inflammatory response. Examples of other 11 agents are provided in Walton et al, Inhibition of Prostoglandin E2 Synthesis in 12 Abdominal Aortic Aneurysms, Circulation, July 6, 1999, 48-54; Tambiah et al, 13 Provocation of Experimental Aortic Inflammation Mediators and Chlamydia 14 Pneumoniae, Brit. J. Surgef-y 88 (7), 935-940; Franklin et al, Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis, Brit.
J.
16 Surgery 86 (6), 771-775; Xu et al, Spl Increases Expression of Cyclooxygenase-2 in 17 Hypoxic Vascular Endothelium, J. Biological Chemistry 275 (32) 24583-24589;
and 18 Pyo et al, Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) 19 Suppresses Development of Experimental Abdominal Aortic Aneurysms, J.
Clinical Investigation 105 (11),1641-1649 which are all incorporated by reference in their 21 entireties.
22 [0060] The delivery guide 12 can be deployed through the surrounding tissue 23 and into the lumen wal18 and/or the lumen 4. As illustrated in Figures 45 and 46 of 24 U.S. Patent Application No. 10/844,247 for a toggle deployment device, the arteriotomy device 2 can have a pressure check port. The pressure check port can be 1 in fluid communication with a sensor or port on or near the handle of the arteriotomy 2 device 2, such as an external lumen where blood flow can be observed, for example 3 from flow from the end of an external tube or port and/or through a transparent or 4 translucent window. The pressure check port can facilitate deployment of the arteriotomy device 2 to a location where the pressure check port is introduced to 6 pressure, for example when the pressure check port enters the biological lumen 4.
7 The sensor or port on or near the handle of the arteriotomy device 2 will signal that 8 the pressure check port has been placed into the biological lumen 4 (e.g., by 9 displaying a small amount of blood flow). The pressure check port can be deployed into the biological lumen 4 and then withdrawn from the biological lumen 4 to the 11 point where the lumen wall 8 just stops the pressure in the pressure check port. An 12 entry wall retainer port can additionally perform the function as described herein for 13 the pressure check port.
14 [0061] The delivery guide 12 can form a first arteriotomy 22. When the anchor 14 is properly located in the lumen 4, a luminal retainer 24 and/or an entry wall 16 retainer 26 can be deployed from the anchor 14 and/or the delivery guide 12. The 17 anchor 14, and/or luminal retainer 24, and1or entry wall retainer 26 can be wires, rods, 18 inflatable balloons, or combinations thereof. The anchor 14, and/or luminal retainer 19 24, and/or entry wall retainer 26 can be separate, integral or a single component.
[0062] When the anchor 14 is properly located in the lumen 4, the introduction 21 device 6 can be translated, as shown by arrow. The introduction device can form a 22 second arteriotomy 28. The introduction device 6 can create a cleavage 30 between 23 the lumen wall 8 and the surrounding tissue 10. The introduction device 6 can cleave 24 a plane in the lumen wall 8, as shown in Figure 2. The cleavage 30 and/or cleavage plane can be substantially parallel with a lumen wall surface 32. The introduction 1 device 6 can be adjacent to the adventitia in a blood vessel. The introduction device 6 2 can be advanced along the subintimal or submedial cleavage plane in a blood vessel.
3 [0063] Once the lumen wal18, and/or the surrounding tissue 10, and/or the 4 cleavage 30 has been cleaved, a subintimal angioplasty can be performed as known to one having ordinary skill in the art. Once the lumen wal18, and/or the surrounding 6 tissue 10, and/or the cleavage 30 has been cleaved, a remote endarterectomy can be 7 performed as known to one having ordinary skill in the art.
8 10064] The introduction device 6 can have one or more straights and/or bends.
9 Various bent introduction devices 34 and straight introduction devices 36 can be swapped during use to selectively cleave the lumen wall 8 and/or the surrounding 11 tissue 10 and/or the cleavage 30. Tools, such as guides (e.g., guidewires), can be 12 inserted through hollow introduction devices 6 to selectively cleave.
13 [0065] As shown in Figure 3, when a bend 34 in the introduction device 6 moves 14 into the lumen wall 8, the introduction device 6 can rotate and slope, as shown by arrow, toward the biological lumen 4. The bend 34 in the introduction device 6 can 16 continue to rotate the introduction device 6 toward the biological lumen 4.
When the 17 introduction device 6 is sloping, the introduction angle 20 can be from about 0 to 18 about 120 , more narrowly from about 5 to about 45 , yet more narrowly from about 19 10 to about 30 , for example about 15 .
[0066] Figure 4 illustrates that the introduction device 6 can be further translated, 21 as shown by, arrow. The introduction device 6 can enter the lumen 4.
22 [0067] The introduction device 6 can pass through an introduction run 38 and an 23 introduction rise 40. The introduction run.38 can.be the component of the length of 24 the introductidn device *6 in the lumen wall 8 that is parallel to the lumen wall 8. The introduction run 38 can be the component of the length parallel to the lumen wa118 I between the opening of the second arteriotomy 28 on the outside of the lumen wall 8 2 and the opening of the second arteriotomy 28 on the inside lumen wall surface 32.
3 The introduction run 38 can be from about 0.10 cm (0.010 in.) to about 3.810 cm 4 (1.500 in.), for example about 0.64 cm (0.25 in.).
[0068] The introduction rise 40 can be the component of the length of the 6 introduction device 6 in the lumen wall 8 that is perpendicular to the lumen wal18.
7 The introduction rise 40 can be the component of the length perpendicular to the 8 lumen wall 8 between the opening of the second arteriotomy 28 on the outside of the 9 lumen wal18 and the opening of the second arteriotomy 28 on the inside lumen wall surface 32. The introduction rise 40 can be from about 0.51 mm (0.020 in.) to about 11 5.08 mm (0.200 in.), for example about 1.0 mm (0.040 in.).
12 [0069] An introduction slope can be the ratio of the introduction rise 40 to the 13 introduction run 38. The introduction slope can be from about 1/2 to about 1/40 or less, 14 for example about 1/6, also for example about 1/3. The introduction slope can be, for examples, equal to or less than about 1/2 or 1/3, more narrowly equal to or less than 16 about 1/3 or 1/4, yet more narrowly equal to or less than about 1/5 or 1/6a even still more 17 narrowly than about equal to or less than about 1/10.
18 [0070] The introduction rise 40 and the introduction run 38 can be components of 19 an introduction vector. The introduction'run 38 can be the component.of the introduction vector parallel to the lumen wall S. The introduction rise 40 can be the 21 component of the introduction vector perpendicular to the lumen wall 8. The 22 introduction vector can be a vector from an outer opening 42 to an inner opening 44.
23 The outer opening 42 can be a temporary or permanent opening in the lumen wall 8 or 24 in the surrounding tissue 10 formed by the initial translation of the introduction device 1 6 out of the delivery guide 12. The inner opening 44 can be a temporary or permanent 2 opening on the lumen wall surfaca 32.
3 [0071] Figure 5 illustrates that the introduction device 6 can act as a pathway for 4 a luminal tool, for example a guidewire 46.
[0072] An introducer sheath (not shown) can be inserted over the guidewire 46 6 and/or.over or through the introduction device 6. The introducer sheath can be less 7 than about 22 French (7.3 mm, 0.29 in. diameter) or less than the diameter of the 8 lumen to which the introducer sheath is introduced. The introducer sheath can be, for 9 examples, about 6 French (2.3 mm, 0.092 in. diameter), and about 8 French (2.67 mm, 0.105 in. diameter). The introducer sheath can be known to one having ordinary skill 11 in the art, for example the introducer sheath described in U.S. Patent No.
5,183,464 to 12 Dubrul, et al.
13 [0073] The introducer sheath can be inserted into the second arteriotomy 28. The 14 introducer sheath can expand the second arteriotomy 28 to a desired or workable size.
The introducer sheath can be inserted into the second arteriotomy 28 before and/or 16 after and/or concurrently with when the filler, described infra, is deployed.and/or 17 other closure methods or devices are used.
18 [0074] Figures 6 and 7 illustrate an exemplary biological lumen 4 after the 19 arteriotomy device 2 has been deployed to, and removed from, the biological lumen 4.
The biological lumen 4 can have the second arteriotomy 28. The biological lumen 4 21 can have a first web 48 on one side of the second arteriotomy 28, and a second web 22 50 on the opposite side of the second arteriotomy 28. The blood pressure 52, shown 23 by arrows, on the first and second webs 48 and 50 can self-seal the second 24 arteriotomy 28.
1 [0075] The second arteriotomy 28 can have an arteriotomy cross-section that can 2 have an arteriotomy diameter 54. The arteriotomy diameter 54 can be from about 0.5 3 mm (0.020 in.) to about 400 mm (15 in.), yet a narrower range from about 1.0 mm 4 (0.040 in.) to about 10.2 mm (0.400 in.), for example about 2.54 mm (0.100 in.). The arteriotomy diameter 54 can be about the diameter of the introduction device 6.
6 [0076] The arteriotomy cross-section can be non-circular. The arteriotomy can 7 have an arteriotomy width and an arteriotomy height. The arteriotomy width can be 8 about half the circumference of the arteriotomy. The arteriotomy width can be from 9 about 1.0 mm (0.040 in.) to about 10.2 mm (0.400 in.), for example about 4.06 mm (0.160 in.).
11 [0077] The arteriotomy height 152 can be less than about 0.51 mm (0.020 in.), 12 more narrowly, less than about 0.38 mm (0.015 in.). The arteriotomy height can be 13 from about 0.25 mm (0.010 in.) to about 1.3 mm (0.050 in.), for example about 0.38 14 mm (0.015 in.). The arteriotomy diameter, and/or height, and/or width can be small enough to enable cell growth, blood clotting, acoustic sealing, heat sealing, gluing, 16 enhanced self-sealing and combinations thereof across the second arteriotomy 28.
17 [0078] The delivery guide 12 and/or other components of the arteriotomy device 2 18 can form a delivery path 56 during use. During percutaneous use, the delivery path 19 can extend to the skin 13 8.
[0079] The second arteriotomy 28 can have a flat 58 and a slope 60. The flat 21 can be the cleavage 30 between the lumen wall 8 and the surrounding tissue.
22 [0080] Figure 8 illustrates that the second arteriotomy 28 can have a first flat 58, a 23 first slope 64, a second flat 66, and a second slope 68. The second arteriotomy 28 24 having multiple flats and slopes can be made from one or more introduction devices 6 that can have various geometries.
1 [0081]'. Figure 9 illustrates that the second arteriotomy 28, for example in the flat 2 58 and/or the slope 60, can be filled with a filler 70. The filler 70 can be a solid single 3 component, multiple solid components (e.g., beads), a biocompatible epoxy, or 4 combinations thereof The filler 70 can be completely or partially bioabsorbable, bioresorbable, bioadsorbable or combinations thereof. The filler 70 can be made from 6 homografts, heterografts or combinations thereof. The filler 70 can be made from 7 autografts, allografts or combinations thereof.
8 [0082] The filler 70 can be delivered (e.g., injected and/or implanted) into the 9 second arteriotomy 28 through the surrounding tissue 10, for example by percutaneous injection. The filler 70 can be delivered (e.g., injected and/or 11 implanted) into the second arteriotomy 28 through the second arteriotomy 28, for 12 example via the introduction device 6 during introduction and/or removal of the 13 introduction device 6.
14 [0083] The filler 70 can be permanently or temporarily deployed. The filler can biodissolve after hemostasis is achieved and/or after the arteriotomy is 16 substantially or completely healed. The filler 70 can be maintained from about 15 17 minutes to about 24 hours or more, for example about 120 minutes.
18 [0084] Figure 10 illustrates that the filler can be in the cleavage 30, not in the 19 second arteriotomy 28. The filler 70 can exert a filler pressure 72 on the second arteriotomy 28, for example on the flat 58 and/or slope 60. The second arteriotomy 21 28 can be compressed by the blood pressure =52 and the filler pressure 72.
22 [0085] Figure 11 illustrates that the filler can be in the in the cleavage 30, not in 23 the second arteriotomy 28. The filler 70 can exert filler pressure 72 against the .24 second flat 66 and/or first slope 64 and/or other sections of the second arteriotomy 28.
1 [0086] The filler 70 can be between the second arteriotomy 28 and the lumen 2 (not shown). The filler 70 can be in the surrounding tissue 10.
3 [0087] Figures 12 and 13 illustrate the arteriotomy device 2. The arteriotomy 4 device 2 can have a handle 74 that can be integral with or fixedly attached to a delivery guide extension 76. The delivery guide extension 76can be integraY
with or 6 fixedly attached to the delivery guide 12. The anchor 14 can extend from, and be 7 slidably and/or fixedly attached to or integral with, the delivery guide 12.
8 [0088] The anchor 14 can have an anchor first length 78 extending from the 9 delivery guide 12. The anchor 14 can have an anchor first bend 80 at the end of the first anchor length 78 distal to the delivery guide 12. An anchor second length 82 can 11 extend at a first end from the anchor first bend 80. A second end of the anchor second 12 length 82 can have an anchor second bend 84. An anchor third length 86 can extend 13 from the anchor second bend 84. The anchor third length 86 can terminate.
The 14 anchor 14 can have any combination of lengths and bends.
[0089] The radius of curvature for the anchor bends 80 and 84 can be from about 16 0.1 mm (0.004 in.) to about.2.0 mm (0.079 in.). The anchor lengths on both sides of 17 any anchor bend can form an anchoring angle. The anchoring angles can be from 18 about 90 to about 160 , more narrowly from about 120 to about 150 , for example 19 about 135 . The anchor 14 can have a cross-section having an anchor diameter from about 0.38 min (0.015 in.) to about 1.0 mm (0.039 in.), for example about 0.71 mm 21 (0.028 in.).
22 [0090] The anchor third length 86 can have an anchor tip 88. The anchor tip 23 can be narrowed, widened, sharpened, dulled, or otherwise configured to promote 24 sharp or blunt dissection. The anchor tip 88 can have an anchor end port 90. The anchor end port 90 can be in communication with an anchor guidewire lumen (not 1 shown). The anchor guidewire lumen can be in communication with a guide lumen 2 92 in the delivery guide extension 76, and/or the handle 74, and/or a third contro194.
3 The guide lumen 92 can have open access along the delivery guide extension 76, 4 and/or along the handle 74, and/or along the third contro194 (as shown).
[0091] The handle 74 can have a first control 96. The first control 96 can be 6 slidably attached to a control slide 98. The first contro196 can be configured to be 7 ergonomically receptive to be activated a digit and/or a palm.
8 [0092] The handle 74 can have a second control 100. The second control 100 can 9 be rotatably attached to the handle 74, for example at a control pivot 102.
The second control 100 can have a tab 104. The tab 104 can be configured to be ergonomically 11 receptive to be activated by a digit and/or a palm.
12 [0093] Tlhe handle 74 can have a third control 94. The third control can be 13 slidably attached to the handle 74. The third control 94 can have or be a plunger. The 14 third control 94 can have a press 106. The press 106 can be configured to be ergonomically receptive to be activated by a digit and/or a palm. The handle 74 can 16 have one or more grips 108. The grips 108 can be configured to be ergonomically 17 receptive to be held by a digit and/or a palm.
18 [0094] The configuration of any of the first, second or third controls 96, 100 and 19 94 can be any configuration (e.g., the first control can have the rotatable lever of the second control 100).
21 [0095] A guidewire 46 can be in proximity to the anchor tip 88.
22 [0096] Figures 14 and 15 illustrate that the guidewire 46 can be inserted into the 23 anchor end port 90,_ as shown by arrows. The guidewire 46 can be fed through the 24 anchor guidewire lumeri and the guide lumen 92. The guidewire 46 can exit through the open section of the guide lumen 92.
1 [0097] The guidewire 46 can be used to deploy the arteriotomy device to a desired 2 location in a lumen. The arteriotomy device 2 can be translated, for example 3 percutaneously, over and along the guidewire 46. If the guidewire 46 is in a lumen, 4 the arteriotomy device 2 can be translated along the guidewire 46, for example, until blood appears at the pressure check port.
6 [0098] Figure 16 illustrates that the first control 96 can be activated, as shown by 7 arrow. The first control 96 can be translated along the control slide 98.
Activating 8 the first control 96 can translatably and/or rotatably deploy the luminal retainer 24, as 9 shown by arrow in Figure 17.
[0099] The luminal retainer 24 can be a wire, scaffold or stent - for example made 11 from a deformable or resilient material, such as a shape memory alloy - an inflatable 12 balloon, or combinations thereof. Intralumenal inflatable balloons, sucll as those 13 inflated with saline solution or carbon dioxide, are known to those having ordinary 14 skill in the art. The luminal retainer 24 can extend into the delivery guide 12.
[0100] Figure 17 illustrates that the luminal retainer 24 can be deployed, as shown by 16 arrow, for example due to the activation of the first contro196. The luminal retainer 47 24 can have a first stressed configuration. The luminal retainer 24 can have a second 18 relaxed configuration. The luminal retainer 24 can be in a relaxed or a stressed 19 configu.ration prior to deployment. The luminal retainer 24 can be in a relaxed or a stressed.configuration after deployment. The relaxed configuration of the luminal 21 retainer 24 can be the deployed configuration of the luminal retainer 24.
22 [0101] The luminal retainer 24 can be configured to press against the lumen 4 during 23 use. The luminal retainer can be deployed by translating, rotating or a combination 24 thereof, with respect to the anchor 14.
1 [0102] The luminal retainer 24 can deploy from the anchor 14. The luminal retainer 2 24 can deploy from a luminal retainer port (not shown). The luminal retainer 24 can 3 have a luminal retainer deployed diameter. The luminal retainer deployed diameter 4 can be from about 2.54 mm (0.100 in.) to about 10.2 mm (0.400 in.), for example about 6.35 mm (0.250 in.).
6 [0103] Figures 18 illustrates that the second control 100 can be activated, as shown by 7 arrow. The second control 100 can be rotated around the control pivot 102.
8 Activating the second control can translatably and/or rotatably retract the anchor 14, 9 as shown by arrows in Figure 19.
[0104] Figure 19 illustrates that the anchor 14 can translate both parallel and/or 11 perpendicular to the delivery guide 12.
12 [0105] The anchor first length 78 can have an anchor shift 110 or small inflection.
13 The anchor shift 110 can be configured wherein the anchor first length 78 shifts 14 perpendicular to the longitudinal axis of the delivery guide 12, as seen in Figure 19.
An introduction lumen exit port 112 can be covered by the anchor first length 78, for 16 example, before the anchor is retracted into the delivery guide 12.
17 [0106] When the anchor is retracted into the delivery guide 12, an introduction lumen 18 exit port 112 can be exposed. When the anchor is retracted into the delivery guide 12, 19 the anchor shift 110, laterally positioned compared to the rest of the anchor first length 78, can expose the introduction lumen exit port 112. When the anchor is 21 retracted into the delivery guide 12, the anchor shift 110, laterally positioned 22 compared to the rest of the anchor first length 78, can force the entire anchor 14 to 23 move laterally, thereby exposing the introduction lumen exit port 112.
24 [0107] Figure 20 illustrates that the third contro194 can be activated, as shown by arrow. The third control 94 can be translated with respect to the handle 74.
i Activating the third control can translatably deploy the introduction device 6, as 2 shown by arrow in Figure 21.
3 [0108] The introduction device 6 can have an introduction device diameter.
The 4 introduction device diameter can be from about 0.25 mm (0.010 in.) to about 1.0 mm (0.039 in.), for example about 0.56 mm (0.022 in.).
6 [0109] The arteriotomy device 2 can be configured to deploy the introduction device 7 6 from the anchor 14 and/or the delivery guide 12 (as shown). The anchor 14 and/or 8 delivery guide 12 can have the introduction lumen exit port 112. The introduction 9 device 6 can deploy through the introduction lumen exit port 112. The introduction device 6 can be a solid or hollow needle, or combinations thereof.
11 [0110] Figure 22 illustrates that the distance perpendicular to the introduction device 12 6 between the introduction lumen exit port 112 to the anchor first length 78 can be 13 substantially and/or completely equal to the introduction rise 40. The anchor 14 can 14 have one or more radiopaque marks. For example, the anchor first length 78 can have a first radiopaque mark 114. The first radiopaque mark 114 can be significantly 16 longer along the anchor first length 78 than the first radiopaque mark 114 is tall or 17 wide. The delivery guide 12 can have a second radiopaque mark 116. The second 18 radiopaque mark 116 can be parallel and aligned with the path of the introduction 19 device 6 where the introduction device 6 exits the introduction lumen exit port 112.
The user can view a radiograph or to assist in the placement of the arteriotomy device 21 2.
22 [0111] Figure 23 illustrates that the arteriotomy device can have a first, second and 23 third radiopaque marks 114, 116 and 118. The first radiopaque mark 114 can be on 24 the handle. The second radiopaque mark 116 can be on the delivery guide extension 76. The third radiopaque mark 118 can be on the anchor 14. A straight alignment 1 axis 120 can pass through the first, second and third radiopaque marks 114, 116 and 2 118. The user can utilize the alignment axis 120 to assist in the placement of the 3 arteriotomy device 2, for example while viewing a radiograph.
4 [0112] The radiopaque marks can be marks for any type of medical imagining.
For example, the marks could be sono-opaque and/or sono-reflective for use with 6 sonographs.
7 [0113] Figure 24 illustrates that the third contro194 can be activated further, for 8 example, by continuing to translate the third contro194 toward the handle 74, as 9 shown by arrow. Activating or re-activating the third control can translatably deploy the introduction device 6, as shown by arrow in Figure 25.
11 [0114] The introduction device 6 can have a bend 34. The bend 34 can be in a 12 relaxed configuration of the introduction device 6. If the introduction device 6 is 13 deployed far enough, the bend 34 can rotate the introduction device 6 toward the 14 lumen 4.
[0115] The first, second and third controls 96, 100 and 94 can have lockouts to 16 prevent the controls 96, 100 and 94 from being activated incorrectly (e.g., to prevent 17 use in the wrong order).
18 [0116] Figure 26 illustrates that the luminal retainer 24 can form a circular, oval, or 19 spiral configuration. Figure 27 illustrates that the anchor 14 can have a luminal retainer exit port 122.
21 [0117] Figures 28 through 32 illustrate various configurations of the luminal retainer 22 24 in the anchor 14 prior to deployment. Figure 28 illustrates that one end of the 23 luminal retainer can be fixedly or rotatably attached to the anchor 14. The luminal 24 retainer 24 can have a ball 124 and the anchor 14 can have a socket 126.
The ball 124 can have an interference fit in the socket 126. When the deployment force is applied, I shown by arrow, the luminal retainer 24 can relax, if pre-stressed (e.g., heat-treated to 2 a specific shape), and/or be forced into buckling out through the luminal retainer exit 3 port 122.
4 [0118] Figure 29 illustrates that the luminal retainer 24 can be loaded in a loop or spiral configuration in the anchor 14. When the deployment force is applied, as 6 shown by arrow, the loop 128 will naturally expand and exit the luminal retainer port 7 122.
8 [0119] Figure 30 illustrates that the luminal retainer can be pre-formed with a 9 curvature 130. When the deployment force is applied, shown by arrow, the luminal retainer 24 can relax, if pre-stressed (e.g., heat-treated to a specific shape), and/or be 11 forced into buckling into the anchor 14 across from the luminal retainer exit port 122.
12 The luminal retainer 24 can then buckle and/or twist at the weakest point along the 13 length, for example the curvature 130. The luminal retainer 24 can then exit through 14 the luminal retainer exit port 122.
[0120] Figure 31 illustrates that the luminal retainer 24 can be fixed to the anchor 14, 16 for example at a fixation area 132 (e.g., via welding, gluing, snap fitting, etc.). Figure 17 32 illustrates that the embodiments of the luminal retainer can be reversed in direction 18 with respect to the remainder of the arteriotomy device 2.
19 [0121] Figures 33 and 34 illustrate that the luminal retainer 24 can deploy as the loop or spiral. The luminal retainer 24 can deploy out of the luminal retainer exit port 122 21 on the anchor (as shown) and/or the delivery guide 12.
22 [01221 Figures 35 and 36 illustrate that arteriotomy device 2 can be translated deep 23 enough into the lumen 4 to contact the deployed luminal retainer 24 against the lumen 24 wa118 opposite from the arteriotomy 134. Figures 37 and 38 illustrate that the handle 74 can be translated, as shown by arrow in Figure 37, away from the lumen 4.
The 1 luminal retainer 24 can be translated, as shown by arrow in Figure 38, into the lumen 2 wall 8 closest to the arteriotomy 134. The luminal retainer 24 can abut the lumen wall 3 8, for example, acting as the entry wall retainer 26. The delivery guide extension 76 4 can be rotatably attached to the delivery guide 12, for example by a hinge 136.
[0123] Figure 39 illustrates that the handle 74 and the delivery guide extension 76 can 6 rotate around the hinge, as shown by arrows, with respect to the delivery guide 12, the 7 anchor 14 and the luminal retainer 24. Rotated configurations of the handle 74 and 8 the delivery guide extension are shown in phantom lines. The handle 74 and delivery 9 guide extension 76 can be manipulated during use with a minimal impact on the delivery guide 12, the anchor 14 and the luminal retainer 24.
11 [0124] Figure 40 illustrates that the delivery guide extension can be flexible. The 12 handle 74 and the delivery guide extension 76 can rotate around the flexible delivery 13 guide extension 76, as shown by arrows, with respect to the delivery guide 12, the 14 anchor 14 and the luminal retainer 24. Rotated configurations of the handle 74 and the delivery guide extension are shown in phantom lines.
16 [0125] Figure 41 illustrates a first longitudinal section 140 of the delivery guide 12.
17 Figure 42 illustrates a second longitudinal section 142 of the delivery guide 12. The 18 first longitudinal section 140 can be a complete or substantial mirror image of the 19 second longitudinal section 142.
[0126] An extension attachment 144 can be configured to fixedly attach to the 21 delivery guide extension 76. The extension abutment 146 can be configured to abut 22 against and/or fixedly attach to the delivery guide extension 76. The extension 23 attachment 144 and/or extension abutment 146 can form fluid-tight and/or air-tight 24 seals with the delivery guide extension 76.
1 [U127] The anchor lumen 148 can be configured to receive and deploy the anchor 14 2 out the anchor exit port 150. The introducer lumen 152 can be configured to receive 3 and deploy the introduction device 6 out the introduction lumen exit port 112. The 4 relative geometries of the anchor lumen 148, the introducer lumen 152, the anchor exit port 150, and the introduction lumen exit port 112 can be changed to alter the 6 introduction angle 20, introduction run 38, introduction rise 40, and the geometry of 7 the arteriotomy 134 including the geometries of the slopes 60 and flats 58 of the 8 arteriotomy 134.
9 [0128] The delivery guide half attachments 154 can attach the first longitudinal section 140 to the second longitudinal section 142, for example by rotatably attaching 11 to a screw. The seam surfaces 156 of the first longitudinal section 140 can form fluid-12 tight and/or air-tight seals with the seam surfaces 156 of the second longitudinal 13 section 142. The delivery guide tip 158 can be sharpened, dulled, or otherwise 14 configured to aid sharp or blunt dissection.
[0129] Figures 43 through 46 illustrate solid introduction devices 6 that can each have 16 an introduction device shaft 160 that can terminate in an introduction device tip 162.
17 As shown in Figure 43, the introduction device tip 162 can have a centered needle 18 point. The introduction device tip 162 can have an introduction device tip cross-19 section 164. The introduction device tip cross-section 164 can be circular or square or combinations thereof. The introduction device tip can be curved (not shown).
21 [0130] Figure 44 illustrates that the introduction device tip 162 can have an off-center 22 needle point. The introduction device tip cross-section 164 can be circular or square 23 or combinations thereof. The introduction device 6 can be configured to have a flat 24 side along the introduction device shaft 160 and along the introduction device tip 162.
1 [0131] Figure 45 illustrates that the introduction device tip 162 can have a centered 2 chisel point. The introduction device tip cross-section 164 can be oval, rectangular, 3 elliptical, or a combination thereof.
4 [0132] Figure 46 illustrates that the introduction device tip 162 can have a off-centered chisel point. The introduction device tip cross-section 164 can be oval, 6 rectangular, elliptical, or a combination thereof. The introduction device 6 can be 7 configured to have a flat side along the introduction device shaft 160 and along the 8 introduction device tip 162.
9 [0133] Figures 47 through 53 illustrate hollow introduction devices 6 that can each have an introduction device shaft 160 that can terminate in an introduction device tip 11 162. The introduction device shaft 160 can have a hollow guide lumen 92 than can 12 extend to the introduction device tip 162 or to the side of the introduction device shaft 13 160. The guide lumen 92 can terminate at a guide port 166. A guide (e.g., a 14 guidewire or other tool) can be slidably attached to the introduction device 6 in the guide lumen 92. The guide lumen can have a guide shaft 168 that can terminate in a 16 guide tip 170. The guide 172 can exit the introduction device at the guide port 166.
17 [0134] As shown in Figure 47, the introduction device tip 162 can be a centered -18 hollow needle point. The guide tip 170 can be a centered needle point. The guide tip 19 170 can be aligned with the introduction device tip to form a substantially smooth combined tip.
21 [0135] As shown in Figure 48, the introduction device tip 162 can be an off-center 22 hollow needle point. The guide tip 170 can be a centered needle point.
23 [0136] Figure 49 illustrates that the guide shaft 168 can have a key 174 and/or a slot 24 176 (not shown). The introduction device shaft 160 can have a slot 176 and/or a key 174 (not shown). The key 174 on the guide shaft 168 can slidably attach to the slot 1 176 in the introduction device shaft 160. The slidable attachment of the key 174 and 2 slot 176 can prevent the guide shaft 168 from rotating about a longitudinal axis with 3 respect to the introduction device shaft 160.
4 [0137] Figure 50 illustrates that the guide lumen 92 and the guide shaft 168 can be oval. The oval-configurations of the guide lumen 92 and the guide shaft 168 can 6 prevent the guide shaft 168 from rotating about a longitudinal axis with respect to the 7 introduction device shaft 160.
8 [0138] Figure 51 illustrates that the introduction device tip 162 can have a curved end 9 178. The curved end 178 can be configured to fit into a recess 180 in the guide 172.
The recess 180 can have a hook 182. The curved end 178 can have a notch 184.
The 11 hook 182 can interference fit and/or snap fit the notch 184.
12 [0139] Figure 52 illustrates that the guide lumen 92 can be curved. The guide lumen 13 92 can terminate at a guide port 166 in the side of the introduction device shaft 160.
14 [0140] Figure 53 illustrates that the introduction device tip 162 and/or the introduction device shaft (not shown) can be curved. The guide 172 or lengths of the 16 guide 172 can be curved in a relaxed configuration. The guide 172 or lengths of the 17 guide 172 can be curved in a stressed configuration due to the curvature of the 18 introduction device 6.
19 [0141] Any of the introduction devices 6 shown in Figure 43 through Figure 46 can be hollowed and configured identically or similar to the introduction devices 21 illustrated in Figures 47 through Figure 53. Any of the introduction devices 6 shown 22 in Figure 47 through Figure 53 can have no guide lumen and be configured identically 23 or similar to the introduction devices illustrated in Figures 43 through Figure 46.
24 [0142] The guides 172 and/or guide lumens 92 and/or introduction devices 6 can have a lubricious coating or be impregnated to elute a lubricious material.
1 [0143] Figure 54 illustrates that the introduction device 6 can have a relaxed 2 configuration having a flat 58 that can have a bend 34 at one end. A slope can extend 3 from the bend 34. The relaxed configuration of the introduction device 6 can form the 4 arteriotomy configuration, for example, as shown in Figures 7 and 9, during deployment of the introduction device 6 from the delivery guide 12.
6 [0144] Figure 55 illustrates that the introduction device 6 can have a relaxed 7 configuration having a first flat 62 that can have a first bend 186 at one end. A first 8 slope 64 can extend at a first end from the first bend 186. The first slope 64 can have 9 at a second end a second bend 188. A second flat 66 can extend at a first end from the second bend 188. The second flat 66 can have at a second end a third bend 190.
A
11 second slope 68 can extend from the third bend 190. The relaxed configuration of the 12 introduction device 6 can form the arteriotomy configuration, for example, as shown 13 in Figures 8, 10 and 11, during deployment of the introduction device 6 from the 14 delivery guide 12.
[0145] The introduction device 6, for example a hollow introduction device 6, can act 16 as a pathway for a luminal tool, for example tools such as a guidewire 46, to be 17 deployed into the lumen 4. The introduction device 6, for example a solid 18 introduction device 6, can- be removed from the second arteriotomy 28 and the 19 luminal tool can be deployed through, for example, the introduction lumen exit port 112, and the second arteriotomy 28. The introduction device 6, or part thereof, can be 21 the luminal tool, for example the guide 172. The introduction device 6 can be fiuther 22 deployed and used as a luminal tool after passing through the lumen wall 8.
23 [0146] The guide 172 can remain substantially in place after the arteriotomy device 2 24 is removed. A portion of the guide 172 can be outside the lumen 4 and another portion of the guide 172 can be inside the lumen 4. The guide proximal end can then 1 be attached to additional devices and implants to guide the devices and implants into 2 the lumen. The filler 70 can be added after additional procedures are completed and 3 the guide 172 is removed, or before the guide 172 is removed, using the guide 172 to 4 redeploy the arteriotomy device 2 back to the arteriotomy 134 to deliver the filler 70.
7 [0147] The elements of the arteriotomy device 2, and those of any other devices and 8 components disclosed herein, can be directly attached by, for example, melting, 9 screwing, gluing, welding or use of an interference fit or pressure fit such as crimping, snapping, or combining methods thereof. The elements can be integrated, for 11 example, molding, die cutting, laser cutting, electrical discharge machining (EDM) or 12 stamping from a single piece or material. Any other methods can be used as known to 13 those having ordinary skill in the art.
14 [0148] Integrated parts can be made from pre-formed resilient materials, for example resilient alloys (e.g., Nitinol, ELGILOYO) that are preformed and biased into the 16 post-deploynlent shape and then compressed into the deployment shape as known to 17 those having ordinary skill, in the art.
18 [0149] Any elements of the arteriotomy device 2, and those of any other devices and 19 components disclosed herein, including the supplemental closure devices, as a whole after assembly, can be coated by dip-coating, brush-coating or spray-coating methods 21 known to one having ordinary skill in the art.
22 [0150] One example of a method used to coat a medical device for vascular use is 23 provided in U.S. Patent No. 6,358,556 by Ding et al. and hereby incorporated by 24 reference in its entirety. Time release coating methods known to one having ordinary 1 skill in the art can also be used to delay the release of an agent in the coating, for 2 example the coatings on the supplemental closure- devices.
3 [0151] Any elements herein can be covered with a fabric, for example polyester (e.g., 4 DACRON from E. I. du Pont de Nemours and Company, Wilmington, DE), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations 6 thereof. Methods of covering an implantable device with fabric are known to those 7 having ordinary skill in the art.
8 [0152] As shown in Figures 13, 41 and 42, the delivery guide 12 can be fixedly 9 composited, for example with a weld, unitary construction (e.g., by casting), snap fitting components, a screw 192, or combinations thereof. The screw 192 can attach 11 the delivery guide 12 to the delivery guide extension 76, for example by screwing 12 through the delivery guide and/or by squeezing the delivery guide onto the delivery 13 guide extension.
14 [0153] The radiopaque marks can be attached to the elements and/or coated on the surface of the elements and/or manufactured integrally in the elements.
16 [0154] The introduction device 6, guide 172, anchor 14, luminal retainer 24, entry 17 wall retainer 26, any other elements, or combinations thereof can be heat set in a 18 relaxed configuration using methods know to those having ordinary skill in the art.
19 [0155] It is apparent to one skilled in the art that various changes and modifications can be made to this disclosure, and equivalents employed, without departing from the 21 spirit and scope of the invention. Elements shown with any embodiment are 22 exemplary for the specific embodiment and can be used on other embodiments within 23 this disclosure.
[0062] When the anchor 14 is properly located in the lumen 4, the introduction 21 device 6 can be translated, as shown by arrow. The introduction device can form a 22 second arteriotomy 28. The introduction device 6 can create a cleavage 30 between 23 the lumen wall 8 and the surrounding tissue 10. The introduction device 6 can cleave 24 a plane in the lumen wall 8, as shown in Figure 2. The cleavage 30 and/or cleavage plane can be substantially parallel with a lumen wall surface 32. The introduction 1 device 6 can be adjacent to the adventitia in a blood vessel. The introduction device 6 2 can be advanced along the subintimal or submedial cleavage plane in a blood vessel.
3 [0063] Once the lumen wal18, and/or the surrounding tissue 10, and/or the 4 cleavage 30 has been cleaved, a subintimal angioplasty can be performed as known to one having ordinary skill in the art. Once the lumen wal18, and/or the surrounding 6 tissue 10, and/or the cleavage 30 has been cleaved, a remote endarterectomy can be 7 performed as known to one having ordinary skill in the art.
8 10064] The introduction device 6 can have one or more straights and/or bends.
9 Various bent introduction devices 34 and straight introduction devices 36 can be swapped during use to selectively cleave the lumen wall 8 and/or the surrounding 11 tissue 10 and/or the cleavage 30. Tools, such as guides (e.g., guidewires), can be 12 inserted through hollow introduction devices 6 to selectively cleave.
13 [0065] As shown in Figure 3, when a bend 34 in the introduction device 6 moves 14 into the lumen wall 8, the introduction device 6 can rotate and slope, as shown by arrow, toward the biological lumen 4. The bend 34 in the introduction device 6 can 16 continue to rotate the introduction device 6 toward the biological lumen 4.
When the 17 introduction device 6 is sloping, the introduction angle 20 can be from about 0 to 18 about 120 , more narrowly from about 5 to about 45 , yet more narrowly from about 19 10 to about 30 , for example about 15 .
[0066] Figure 4 illustrates that the introduction device 6 can be further translated, 21 as shown by, arrow. The introduction device 6 can enter the lumen 4.
22 [0067] The introduction device 6 can pass through an introduction run 38 and an 23 introduction rise 40. The introduction run.38 can.be the component of the length of 24 the introductidn device *6 in the lumen wall 8 that is parallel to the lumen wall 8. The introduction run 38 can be the component of the length parallel to the lumen wa118 I between the opening of the second arteriotomy 28 on the outside of the lumen wall 8 2 and the opening of the second arteriotomy 28 on the inside lumen wall surface 32.
3 The introduction run 38 can be from about 0.10 cm (0.010 in.) to about 3.810 cm 4 (1.500 in.), for example about 0.64 cm (0.25 in.).
[0068] The introduction rise 40 can be the component of the length of the 6 introduction device 6 in the lumen wall 8 that is perpendicular to the lumen wal18.
7 The introduction rise 40 can be the component of the length perpendicular to the 8 lumen wall 8 between the opening of the second arteriotomy 28 on the outside of the 9 lumen wal18 and the opening of the second arteriotomy 28 on the inside lumen wall surface 32. The introduction rise 40 can be from about 0.51 mm (0.020 in.) to about 11 5.08 mm (0.200 in.), for example about 1.0 mm (0.040 in.).
12 [0069] An introduction slope can be the ratio of the introduction rise 40 to the 13 introduction run 38. The introduction slope can be from about 1/2 to about 1/40 or less, 14 for example about 1/6, also for example about 1/3. The introduction slope can be, for examples, equal to or less than about 1/2 or 1/3, more narrowly equal to or less than 16 about 1/3 or 1/4, yet more narrowly equal to or less than about 1/5 or 1/6a even still more 17 narrowly than about equal to or less than about 1/10.
18 [0070] The introduction rise 40 and the introduction run 38 can be components of 19 an introduction vector. The introduction'run 38 can be the component.of the introduction vector parallel to the lumen wall S. The introduction rise 40 can be the 21 component of the introduction vector perpendicular to the lumen wall 8. The 22 introduction vector can be a vector from an outer opening 42 to an inner opening 44.
23 The outer opening 42 can be a temporary or permanent opening in the lumen wall 8 or 24 in the surrounding tissue 10 formed by the initial translation of the introduction device 1 6 out of the delivery guide 12. The inner opening 44 can be a temporary or permanent 2 opening on the lumen wall surfaca 32.
3 [0071] Figure 5 illustrates that the introduction device 6 can act as a pathway for 4 a luminal tool, for example a guidewire 46.
[0072] An introducer sheath (not shown) can be inserted over the guidewire 46 6 and/or.over or through the introduction device 6. The introducer sheath can be less 7 than about 22 French (7.3 mm, 0.29 in. diameter) or less than the diameter of the 8 lumen to which the introducer sheath is introduced. The introducer sheath can be, for 9 examples, about 6 French (2.3 mm, 0.092 in. diameter), and about 8 French (2.67 mm, 0.105 in. diameter). The introducer sheath can be known to one having ordinary skill 11 in the art, for example the introducer sheath described in U.S. Patent No.
5,183,464 to 12 Dubrul, et al.
13 [0073] The introducer sheath can be inserted into the second arteriotomy 28. The 14 introducer sheath can expand the second arteriotomy 28 to a desired or workable size.
The introducer sheath can be inserted into the second arteriotomy 28 before and/or 16 after and/or concurrently with when the filler, described infra, is deployed.and/or 17 other closure methods or devices are used.
18 [0074] Figures 6 and 7 illustrate an exemplary biological lumen 4 after the 19 arteriotomy device 2 has been deployed to, and removed from, the biological lumen 4.
The biological lumen 4 can have the second arteriotomy 28. The biological lumen 4 21 can have a first web 48 on one side of the second arteriotomy 28, and a second web 22 50 on the opposite side of the second arteriotomy 28. The blood pressure 52, shown 23 by arrows, on the first and second webs 48 and 50 can self-seal the second 24 arteriotomy 28.
1 [0075] The second arteriotomy 28 can have an arteriotomy cross-section that can 2 have an arteriotomy diameter 54. The arteriotomy diameter 54 can be from about 0.5 3 mm (0.020 in.) to about 400 mm (15 in.), yet a narrower range from about 1.0 mm 4 (0.040 in.) to about 10.2 mm (0.400 in.), for example about 2.54 mm (0.100 in.). The arteriotomy diameter 54 can be about the diameter of the introduction device 6.
6 [0076] The arteriotomy cross-section can be non-circular. The arteriotomy can 7 have an arteriotomy width and an arteriotomy height. The arteriotomy width can be 8 about half the circumference of the arteriotomy. The arteriotomy width can be from 9 about 1.0 mm (0.040 in.) to about 10.2 mm (0.400 in.), for example about 4.06 mm (0.160 in.).
11 [0077] The arteriotomy height 152 can be less than about 0.51 mm (0.020 in.), 12 more narrowly, less than about 0.38 mm (0.015 in.). The arteriotomy height can be 13 from about 0.25 mm (0.010 in.) to about 1.3 mm (0.050 in.), for example about 0.38 14 mm (0.015 in.). The arteriotomy diameter, and/or height, and/or width can be small enough to enable cell growth, blood clotting, acoustic sealing, heat sealing, gluing, 16 enhanced self-sealing and combinations thereof across the second arteriotomy 28.
17 [0078] The delivery guide 12 and/or other components of the arteriotomy device 2 18 can form a delivery path 56 during use. During percutaneous use, the delivery path 19 can extend to the skin 13 8.
[0079] The second arteriotomy 28 can have a flat 58 and a slope 60. The flat 21 can be the cleavage 30 between the lumen wall 8 and the surrounding tissue.
22 [0080] Figure 8 illustrates that the second arteriotomy 28 can have a first flat 58, a 23 first slope 64, a second flat 66, and a second slope 68. The second arteriotomy 28 24 having multiple flats and slopes can be made from one or more introduction devices 6 that can have various geometries.
1 [0081]'. Figure 9 illustrates that the second arteriotomy 28, for example in the flat 2 58 and/or the slope 60, can be filled with a filler 70. The filler 70 can be a solid single 3 component, multiple solid components (e.g., beads), a biocompatible epoxy, or 4 combinations thereof The filler 70 can be completely or partially bioabsorbable, bioresorbable, bioadsorbable or combinations thereof. The filler 70 can be made from 6 homografts, heterografts or combinations thereof. The filler 70 can be made from 7 autografts, allografts or combinations thereof.
8 [0082] The filler 70 can be delivered (e.g., injected and/or implanted) into the 9 second arteriotomy 28 through the surrounding tissue 10, for example by percutaneous injection. The filler 70 can be delivered (e.g., injected and/or 11 implanted) into the second arteriotomy 28 through the second arteriotomy 28, for 12 example via the introduction device 6 during introduction and/or removal of the 13 introduction device 6.
14 [0083] The filler 70 can be permanently or temporarily deployed. The filler can biodissolve after hemostasis is achieved and/or after the arteriotomy is 16 substantially or completely healed. The filler 70 can be maintained from about 15 17 minutes to about 24 hours or more, for example about 120 minutes.
18 [0084] Figure 10 illustrates that the filler can be in the cleavage 30, not in the 19 second arteriotomy 28. The filler 70 can exert a filler pressure 72 on the second arteriotomy 28, for example on the flat 58 and/or slope 60. The second arteriotomy 21 28 can be compressed by the blood pressure =52 and the filler pressure 72.
22 [0085] Figure 11 illustrates that the filler can be in the in the cleavage 30, not in 23 the second arteriotomy 28. The filler 70 can exert filler pressure 72 against the .24 second flat 66 and/or first slope 64 and/or other sections of the second arteriotomy 28.
1 [0086] The filler 70 can be between the second arteriotomy 28 and the lumen 2 (not shown). The filler 70 can be in the surrounding tissue 10.
3 [0087] Figures 12 and 13 illustrate the arteriotomy device 2. The arteriotomy 4 device 2 can have a handle 74 that can be integral with or fixedly attached to a delivery guide extension 76. The delivery guide extension 76can be integraY
with or 6 fixedly attached to the delivery guide 12. The anchor 14 can extend from, and be 7 slidably and/or fixedly attached to or integral with, the delivery guide 12.
8 [0088] The anchor 14 can have an anchor first length 78 extending from the 9 delivery guide 12. The anchor 14 can have an anchor first bend 80 at the end of the first anchor length 78 distal to the delivery guide 12. An anchor second length 82 can 11 extend at a first end from the anchor first bend 80. A second end of the anchor second 12 length 82 can have an anchor second bend 84. An anchor third length 86 can extend 13 from the anchor second bend 84. The anchor third length 86 can terminate.
The 14 anchor 14 can have any combination of lengths and bends.
[0089] The radius of curvature for the anchor bends 80 and 84 can be from about 16 0.1 mm (0.004 in.) to about.2.0 mm (0.079 in.). The anchor lengths on both sides of 17 any anchor bend can form an anchoring angle. The anchoring angles can be from 18 about 90 to about 160 , more narrowly from about 120 to about 150 , for example 19 about 135 . The anchor 14 can have a cross-section having an anchor diameter from about 0.38 min (0.015 in.) to about 1.0 mm (0.039 in.), for example about 0.71 mm 21 (0.028 in.).
22 [0090] The anchor third length 86 can have an anchor tip 88. The anchor tip 23 can be narrowed, widened, sharpened, dulled, or otherwise configured to promote 24 sharp or blunt dissection. The anchor tip 88 can have an anchor end port 90. The anchor end port 90 can be in communication with an anchor guidewire lumen (not 1 shown). The anchor guidewire lumen can be in communication with a guide lumen 2 92 in the delivery guide extension 76, and/or the handle 74, and/or a third contro194.
3 The guide lumen 92 can have open access along the delivery guide extension 76, 4 and/or along the handle 74, and/or along the third contro194 (as shown).
[0091] The handle 74 can have a first control 96. The first control 96 can be 6 slidably attached to a control slide 98. The first contro196 can be configured to be 7 ergonomically receptive to be activated a digit and/or a palm.
8 [0092] The handle 74 can have a second control 100. The second control 100 can 9 be rotatably attached to the handle 74, for example at a control pivot 102.
The second control 100 can have a tab 104. The tab 104 can be configured to be ergonomically 11 receptive to be activated by a digit and/or a palm.
12 [0093] Tlhe handle 74 can have a third control 94. The third control can be 13 slidably attached to the handle 74. The third control 94 can have or be a plunger. The 14 third control 94 can have a press 106. The press 106 can be configured to be ergonomically receptive to be activated by a digit and/or a palm. The handle 74 can 16 have one or more grips 108. The grips 108 can be configured to be ergonomically 17 receptive to be held by a digit and/or a palm.
18 [0094] The configuration of any of the first, second or third controls 96, 100 and 19 94 can be any configuration (e.g., the first control can have the rotatable lever of the second control 100).
21 [0095] A guidewire 46 can be in proximity to the anchor tip 88.
22 [0096] Figures 14 and 15 illustrate that the guidewire 46 can be inserted into the 23 anchor end port 90,_ as shown by arrows. The guidewire 46 can be fed through the 24 anchor guidewire lumeri and the guide lumen 92. The guidewire 46 can exit through the open section of the guide lumen 92.
1 [0097] The guidewire 46 can be used to deploy the arteriotomy device to a desired 2 location in a lumen. The arteriotomy device 2 can be translated, for example 3 percutaneously, over and along the guidewire 46. If the guidewire 46 is in a lumen, 4 the arteriotomy device 2 can be translated along the guidewire 46, for example, until blood appears at the pressure check port.
6 [0098] Figure 16 illustrates that the first control 96 can be activated, as shown by 7 arrow. The first control 96 can be translated along the control slide 98.
Activating 8 the first control 96 can translatably and/or rotatably deploy the luminal retainer 24, as 9 shown by arrow in Figure 17.
[0099] The luminal retainer 24 can be a wire, scaffold or stent - for example made 11 from a deformable or resilient material, such as a shape memory alloy - an inflatable 12 balloon, or combinations thereof. Intralumenal inflatable balloons, sucll as those 13 inflated with saline solution or carbon dioxide, are known to those having ordinary 14 skill in the art. The luminal retainer 24 can extend into the delivery guide 12.
[0100] Figure 17 illustrates that the luminal retainer 24 can be deployed, as shown by 16 arrow, for example due to the activation of the first contro196. The luminal retainer 47 24 can have a first stressed configuration. The luminal retainer 24 can have a second 18 relaxed configuration. The luminal retainer 24 can be in a relaxed or a stressed 19 configu.ration prior to deployment. The luminal retainer 24 can be in a relaxed or a stressed.configuration after deployment. The relaxed configuration of the luminal 21 retainer 24 can be the deployed configuration of the luminal retainer 24.
22 [0101] The luminal retainer 24 can be configured to press against the lumen 4 during 23 use. The luminal retainer can be deployed by translating, rotating or a combination 24 thereof, with respect to the anchor 14.
1 [0102] The luminal retainer 24 can deploy from the anchor 14. The luminal retainer 2 24 can deploy from a luminal retainer port (not shown). The luminal retainer 24 can 3 have a luminal retainer deployed diameter. The luminal retainer deployed diameter 4 can be from about 2.54 mm (0.100 in.) to about 10.2 mm (0.400 in.), for example about 6.35 mm (0.250 in.).
6 [0103] Figures 18 illustrates that the second control 100 can be activated, as shown by 7 arrow. The second control 100 can be rotated around the control pivot 102.
8 Activating the second control can translatably and/or rotatably retract the anchor 14, 9 as shown by arrows in Figure 19.
[0104] Figure 19 illustrates that the anchor 14 can translate both parallel and/or 11 perpendicular to the delivery guide 12.
12 [0105] The anchor first length 78 can have an anchor shift 110 or small inflection.
13 The anchor shift 110 can be configured wherein the anchor first length 78 shifts 14 perpendicular to the longitudinal axis of the delivery guide 12, as seen in Figure 19.
An introduction lumen exit port 112 can be covered by the anchor first length 78, for 16 example, before the anchor is retracted into the delivery guide 12.
17 [0106] When the anchor is retracted into the delivery guide 12, an introduction lumen 18 exit port 112 can be exposed. When the anchor is retracted into the delivery guide 12, 19 the anchor shift 110, laterally positioned compared to the rest of the anchor first length 78, can expose the introduction lumen exit port 112. When the anchor is 21 retracted into the delivery guide 12, the anchor shift 110, laterally positioned 22 compared to the rest of the anchor first length 78, can force the entire anchor 14 to 23 move laterally, thereby exposing the introduction lumen exit port 112.
24 [0107] Figure 20 illustrates that the third contro194 can be activated, as shown by arrow. The third control 94 can be translated with respect to the handle 74.
i Activating the third control can translatably deploy the introduction device 6, as 2 shown by arrow in Figure 21.
3 [0108] The introduction device 6 can have an introduction device diameter.
The 4 introduction device diameter can be from about 0.25 mm (0.010 in.) to about 1.0 mm (0.039 in.), for example about 0.56 mm (0.022 in.).
6 [0109] The arteriotomy device 2 can be configured to deploy the introduction device 7 6 from the anchor 14 and/or the delivery guide 12 (as shown). The anchor 14 and/or 8 delivery guide 12 can have the introduction lumen exit port 112. The introduction 9 device 6 can deploy through the introduction lumen exit port 112. The introduction device 6 can be a solid or hollow needle, or combinations thereof.
11 [0110] Figure 22 illustrates that the distance perpendicular to the introduction device 12 6 between the introduction lumen exit port 112 to the anchor first length 78 can be 13 substantially and/or completely equal to the introduction rise 40. The anchor 14 can 14 have one or more radiopaque marks. For example, the anchor first length 78 can have a first radiopaque mark 114. The first radiopaque mark 114 can be significantly 16 longer along the anchor first length 78 than the first radiopaque mark 114 is tall or 17 wide. The delivery guide 12 can have a second radiopaque mark 116. The second 18 radiopaque mark 116 can be parallel and aligned with the path of the introduction 19 device 6 where the introduction device 6 exits the introduction lumen exit port 112.
The user can view a radiograph or to assist in the placement of the arteriotomy device 21 2.
22 [0111] Figure 23 illustrates that the arteriotomy device can have a first, second and 23 third radiopaque marks 114, 116 and 118. The first radiopaque mark 114 can be on 24 the handle. The second radiopaque mark 116 can be on the delivery guide extension 76. The third radiopaque mark 118 can be on the anchor 14. A straight alignment 1 axis 120 can pass through the first, second and third radiopaque marks 114, 116 and 2 118. The user can utilize the alignment axis 120 to assist in the placement of the 3 arteriotomy device 2, for example while viewing a radiograph.
4 [0112] The radiopaque marks can be marks for any type of medical imagining.
For example, the marks could be sono-opaque and/or sono-reflective for use with 6 sonographs.
7 [0113] Figure 24 illustrates that the third contro194 can be activated further, for 8 example, by continuing to translate the third contro194 toward the handle 74, as 9 shown by arrow. Activating or re-activating the third control can translatably deploy the introduction device 6, as shown by arrow in Figure 25.
11 [0114] The introduction device 6 can have a bend 34. The bend 34 can be in a 12 relaxed configuration of the introduction device 6. If the introduction device 6 is 13 deployed far enough, the bend 34 can rotate the introduction device 6 toward the 14 lumen 4.
[0115] The first, second and third controls 96, 100 and 94 can have lockouts to 16 prevent the controls 96, 100 and 94 from being activated incorrectly (e.g., to prevent 17 use in the wrong order).
18 [0116] Figure 26 illustrates that the luminal retainer 24 can form a circular, oval, or 19 spiral configuration. Figure 27 illustrates that the anchor 14 can have a luminal retainer exit port 122.
21 [0117] Figures 28 through 32 illustrate various configurations of the luminal retainer 22 24 in the anchor 14 prior to deployment. Figure 28 illustrates that one end of the 23 luminal retainer can be fixedly or rotatably attached to the anchor 14. The luminal 24 retainer 24 can have a ball 124 and the anchor 14 can have a socket 126.
The ball 124 can have an interference fit in the socket 126. When the deployment force is applied, I shown by arrow, the luminal retainer 24 can relax, if pre-stressed (e.g., heat-treated to 2 a specific shape), and/or be forced into buckling out through the luminal retainer exit 3 port 122.
4 [0118] Figure 29 illustrates that the luminal retainer 24 can be loaded in a loop or spiral configuration in the anchor 14. When the deployment force is applied, as 6 shown by arrow, the loop 128 will naturally expand and exit the luminal retainer port 7 122.
8 [0119] Figure 30 illustrates that the luminal retainer can be pre-formed with a 9 curvature 130. When the deployment force is applied, shown by arrow, the luminal retainer 24 can relax, if pre-stressed (e.g., heat-treated to a specific shape), and/or be 11 forced into buckling into the anchor 14 across from the luminal retainer exit port 122.
12 The luminal retainer 24 can then buckle and/or twist at the weakest point along the 13 length, for example the curvature 130. The luminal retainer 24 can then exit through 14 the luminal retainer exit port 122.
[0120] Figure 31 illustrates that the luminal retainer 24 can be fixed to the anchor 14, 16 for example at a fixation area 132 (e.g., via welding, gluing, snap fitting, etc.). Figure 17 32 illustrates that the embodiments of the luminal retainer can be reversed in direction 18 with respect to the remainder of the arteriotomy device 2.
19 [0121] Figures 33 and 34 illustrate that the luminal retainer 24 can deploy as the loop or spiral. The luminal retainer 24 can deploy out of the luminal retainer exit port 122 21 on the anchor (as shown) and/or the delivery guide 12.
22 [01221 Figures 35 and 36 illustrate that arteriotomy device 2 can be translated deep 23 enough into the lumen 4 to contact the deployed luminal retainer 24 against the lumen 24 wa118 opposite from the arteriotomy 134. Figures 37 and 38 illustrate that the handle 74 can be translated, as shown by arrow in Figure 37, away from the lumen 4.
The 1 luminal retainer 24 can be translated, as shown by arrow in Figure 38, into the lumen 2 wall 8 closest to the arteriotomy 134. The luminal retainer 24 can abut the lumen wall 3 8, for example, acting as the entry wall retainer 26. The delivery guide extension 76 4 can be rotatably attached to the delivery guide 12, for example by a hinge 136.
[0123] Figure 39 illustrates that the handle 74 and the delivery guide extension 76 can 6 rotate around the hinge, as shown by arrows, with respect to the delivery guide 12, the 7 anchor 14 and the luminal retainer 24. Rotated configurations of the handle 74 and 8 the delivery guide extension are shown in phantom lines. The handle 74 and delivery 9 guide extension 76 can be manipulated during use with a minimal impact on the delivery guide 12, the anchor 14 and the luminal retainer 24.
11 [0124] Figure 40 illustrates that the delivery guide extension can be flexible. The 12 handle 74 and the delivery guide extension 76 can rotate around the flexible delivery 13 guide extension 76, as shown by arrows, with respect to the delivery guide 12, the 14 anchor 14 and the luminal retainer 24. Rotated configurations of the handle 74 and the delivery guide extension are shown in phantom lines.
16 [0125] Figure 41 illustrates a first longitudinal section 140 of the delivery guide 12.
17 Figure 42 illustrates a second longitudinal section 142 of the delivery guide 12. The 18 first longitudinal section 140 can be a complete or substantial mirror image of the 19 second longitudinal section 142.
[0126] An extension attachment 144 can be configured to fixedly attach to the 21 delivery guide extension 76. The extension abutment 146 can be configured to abut 22 against and/or fixedly attach to the delivery guide extension 76. The extension 23 attachment 144 and/or extension abutment 146 can form fluid-tight and/or air-tight 24 seals with the delivery guide extension 76.
1 [U127] The anchor lumen 148 can be configured to receive and deploy the anchor 14 2 out the anchor exit port 150. The introducer lumen 152 can be configured to receive 3 and deploy the introduction device 6 out the introduction lumen exit port 112. The 4 relative geometries of the anchor lumen 148, the introducer lumen 152, the anchor exit port 150, and the introduction lumen exit port 112 can be changed to alter the 6 introduction angle 20, introduction run 38, introduction rise 40, and the geometry of 7 the arteriotomy 134 including the geometries of the slopes 60 and flats 58 of the 8 arteriotomy 134.
9 [0128] The delivery guide half attachments 154 can attach the first longitudinal section 140 to the second longitudinal section 142, for example by rotatably attaching 11 to a screw. The seam surfaces 156 of the first longitudinal section 140 can form fluid-12 tight and/or air-tight seals with the seam surfaces 156 of the second longitudinal 13 section 142. The delivery guide tip 158 can be sharpened, dulled, or otherwise 14 configured to aid sharp or blunt dissection.
[0129] Figures 43 through 46 illustrate solid introduction devices 6 that can each have 16 an introduction device shaft 160 that can terminate in an introduction device tip 162.
17 As shown in Figure 43, the introduction device tip 162 can have a centered needle 18 point. The introduction device tip 162 can have an introduction device tip cross-19 section 164. The introduction device tip cross-section 164 can be circular or square or combinations thereof. The introduction device tip can be curved (not shown).
21 [0130] Figure 44 illustrates that the introduction device tip 162 can have an off-center 22 needle point. The introduction device tip cross-section 164 can be circular or square 23 or combinations thereof. The introduction device 6 can be configured to have a flat 24 side along the introduction device shaft 160 and along the introduction device tip 162.
1 [0131] Figure 45 illustrates that the introduction device tip 162 can have a centered 2 chisel point. The introduction device tip cross-section 164 can be oval, rectangular, 3 elliptical, or a combination thereof.
4 [0132] Figure 46 illustrates that the introduction device tip 162 can have a off-centered chisel point. The introduction device tip cross-section 164 can be oval, 6 rectangular, elliptical, or a combination thereof. The introduction device 6 can be 7 configured to have a flat side along the introduction device shaft 160 and along the 8 introduction device tip 162.
9 [0133] Figures 47 through 53 illustrate hollow introduction devices 6 that can each have an introduction device shaft 160 that can terminate in an introduction device tip 11 162. The introduction device shaft 160 can have a hollow guide lumen 92 than can 12 extend to the introduction device tip 162 or to the side of the introduction device shaft 13 160. The guide lumen 92 can terminate at a guide port 166. A guide (e.g., a 14 guidewire or other tool) can be slidably attached to the introduction device 6 in the guide lumen 92. The guide lumen can have a guide shaft 168 that can terminate in a 16 guide tip 170. The guide 172 can exit the introduction device at the guide port 166.
17 [0134] As shown in Figure 47, the introduction device tip 162 can be a centered -18 hollow needle point. The guide tip 170 can be a centered needle point. The guide tip 19 170 can be aligned with the introduction device tip to form a substantially smooth combined tip.
21 [0135] As shown in Figure 48, the introduction device tip 162 can be an off-center 22 hollow needle point. The guide tip 170 can be a centered needle point.
23 [0136] Figure 49 illustrates that the guide shaft 168 can have a key 174 and/or a slot 24 176 (not shown). The introduction device shaft 160 can have a slot 176 and/or a key 174 (not shown). The key 174 on the guide shaft 168 can slidably attach to the slot 1 176 in the introduction device shaft 160. The slidable attachment of the key 174 and 2 slot 176 can prevent the guide shaft 168 from rotating about a longitudinal axis with 3 respect to the introduction device shaft 160.
4 [0137] Figure 50 illustrates that the guide lumen 92 and the guide shaft 168 can be oval. The oval-configurations of the guide lumen 92 and the guide shaft 168 can 6 prevent the guide shaft 168 from rotating about a longitudinal axis with respect to the 7 introduction device shaft 160.
8 [0138] Figure 51 illustrates that the introduction device tip 162 can have a curved end 9 178. The curved end 178 can be configured to fit into a recess 180 in the guide 172.
The recess 180 can have a hook 182. The curved end 178 can have a notch 184.
The 11 hook 182 can interference fit and/or snap fit the notch 184.
12 [0139] Figure 52 illustrates that the guide lumen 92 can be curved. The guide lumen 13 92 can terminate at a guide port 166 in the side of the introduction device shaft 160.
14 [0140] Figure 53 illustrates that the introduction device tip 162 and/or the introduction device shaft (not shown) can be curved. The guide 172 or lengths of the 16 guide 172 can be curved in a relaxed configuration. The guide 172 or lengths of the 17 guide 172 can be curved in a stressed configuration due to the curvature of the 18 introduction device 6.
19 [0141] Any of the introduction devices 6 shown in Figure 43 through Figure 46 can be hollowed and configured identically or similar to the introduction devices 21 illustrated in Figures 47 through Figure 53. Any of the introduction devices 6 shown 22 in Figure 47 through Figure 53 can have no guide lumen and be configured identically 23 or similar to the introduction devices illustrated in Figures 43 through Figure 46.
24 [0142] The guides 172 and/or guide lumens 92 and/or introduction devices 6 can have a lubricious coating or be impregnated to elute a lubricious material.
1 [0143] Figure 54 illustrates that the introduction device 6 can have a relaxed 2 configuration having a flat 58 that can have a bend 34 at one end. A slope can extend 3 from the bend 34. The relaxed configuration of the introduction device 6 can form the 4 arteriotomy configuration, for example, as shown in Figures 7 and 9, during deployment of the introduction device 6 from the delivery guide 12.
6 [0144] Figure 55 illustrates that the introduction device 6 can have a relaxed 7 configuration having a first flat 62 that can have a first bend 186 at one end. A first 8 slope 64 can extend at a first end from the first bend 186. The first slope 64 can have 9 at a second end a second bend 188. A second flat 66 can extend at a first end from the second bend 188. The second flat 66 can have at a second end a third bend 190.
A
11 second slope 68 can extend from the third bend 190. The relaxed configuration of the 12 introduction device 6 can form the arteriotomy configuration, for example, as shown 13 in Figures 8, 10 and 11, during deployment of the introduction device 6 from the 14 delivery guide 12.
[0145] The introduction device 6, for example a hollow introduction device 6, can act 16 as a pathway for a luminal tool, for example tools such as a guidewire 46, to be 17 deployed into the lumen 4. The introduction device 6, for example a solid 18 introduction device 6, can- be removed from the second arteriotomy 28 and the 19 luminal tool can be deployed through, for example, the introduction lumen exit port 112, and the second arteriotomy 28. The introduction device 6, or part thereof, can be 21 the luminal tool, for example the guide 172. The introduction device 6 can be fiuther 22 deployed and used as a luminal tool after passing through the lumen wall 8.
23 [0146] The guide 172 can remain substantially in place after the arteriotomy device 2 24 is removed. A portion of the guide 172 can be outside the lumen 4 and another portion of the guide 172 can be inside the lumen 4. The guide proximal end can then 1 be attached to additional devices and implants to guide the devices and implants into 2 the lumen. The filler 70 can be added after additional procedures are completed and 3 the guide 172 is removed, or before the guide 172 is removed, using the guide 172 to 4 redeploy the arteriotomy device 2 back to the arteriotomy 134 to deliver the filler 70.
7 [0147] The elements of the arteriotomy device 2, and those of any other devices and 8 components disclosed herein, can be directly attached by, for example, melting, 9 screwing, gluing, welding or use of an interference fit or pressure fit such as crimping, snapping, or combining methods thereof. The elements can be integrated, for 11 example, molding, die cutting, laser cutting, electrical discharge machining (EDM) or 12 stamping from a single piece or material. Any other methods can be used as known to 13 those having ordinary skill in the art.
14 [0148] Integrated parts can be made from pre-formed resilient materials, for example resilient alloys (e.g., Nitinol, ELGILOYO) that are preformed and biased into the 16 post-deploynlent shape and then compressed into the deployment shape as known to 17 those having ordinary skill, in the art.
18 [0149] Any elements of the arteriotomy device 2, and those of any other devices and 19 components disclosed herein, including the supplemental closure devices, as a whole after assembly, can be coated by dip-coating, brush-coating or spray-coating methods 21 known to one having ordinary skill in the art.
22 [0150] One example of a method used to coat a medical device for vascular use is 23 provided in U.S. Patent No. 6,358,556 by Ding et al. and hereby incorporated by 24 reference in its entirety. Time release coating methods known to one having ordinary 1 skill in the art can also be used to delay the release of an agent in the coating, for 2 example the coatings on the supplemental closure- devices.
3 [0151] Any elements herein can be covered with a fabric, for example polyester (e.g., 4 DACRON from E. I. du Pont de Nemours and Company, Wilmington, DE), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations 6 thereof. Methods of covering an implantable device with fabric are known to those 7 having ordinary skill in the art.
8 [0152] As shown in Figures 13, 41 and 42, the delivery guide 12 can be fixedly 9 composited, for example with a weld, unitary construction (e.g., by casting), snap fitting components, a screw 192, or combinations thereof. The screw 192 can attach 11 the delivery guide 12 to the delivery guide extension 76, for example by screwing 12 through the delivery guide and/or by squeezing the delivery guide onto the delivery 13 guide extension.
14 [0153] The radiopaque marks can be attached to the elements and/or coated on the surface of the elements and/or manufactured integrally in the elements.
16 [0154] The introduction device 6, guide 172, anchor 14, luminal retainer 24, entry 17 wall retainer 26, any other elements, or combinations thereof can be heat set in a 18 relaxed configuration using methods know to those having ordinary skill in the art.
19 [0155] It is apparent to one skilled in the art that various changes and modifications can be made to this disclosure, and equivalents employed, without departing from the 21 spirit and scope of the invention. Elements shown with any embodiment are 22 exemplary for the specific embodiment and can be used on other embodiments within 23 this disclosure.
Claims (25)
1. A method for accessing a biological lumen having a lumen wall and surrounding tissue, the method comprising:
forming a path between the lumen wall and the surrounding tissue;
extending the path through the lumen wall; and opening the path to the lumen.
forming a path between the lumen wall and the surrounding tissue;
extending the path through the lumen wall; and opening the path to the lumen.
2. The method of Claim 1, wherein forming the path comprises inserting a device between the lumen wall and the surrounding tissue.
3. The method of Claim 2, wherein extending the path comprises inserting the device through the lumen wall.
4. The method of Claim 3, wherein opening the path comprises inserting the device into the lumen.
5. The method of Claim 4, further comprising delivering a filler into the path.
6. The method of Claim 1, further comprising filling the path.
7. The method of Claim 6, wherein filling the path comprises delivering a filler into the path.
8. The method of Claim 7, wherein the filler comprises a solid-setting liquid.
9. The method of Claim 8, wherein the filler comprises an epoxy.
10. The method of Claim 1, further comprising applying pressure to the path
11. The method of Claim 10, Wherein applying the pressure comprises delivering filler adjacent to the path.
12. The method of Claim 11, wherein delivering filler comprises delivering filler between the lumen wall and the surrounding tissue.
13. The method of Claim 11, wherein delivering filler comprises delivering filler in the lumen wall.
14. The method of Claim 11, wherein delivering filler comprises delivering filler in the surrounding tissue.
15. A method for forming an arteriotomy in a lumen having a lumen wall and surrounding tissue, the method comprising:
translating a device substantially between the lumen wall and the surrounding tissue;
turning the device toward the lumen;
translating the device through the lumen wall; and removing the device from the lumen wall.
translating a device substantially between the lumen wall and the surrounding tissue;
turning the device toward the lumen;
translating the device through the lumen wall; and removing the device from the lumen wall.
16. The method of Claim 15, wherein the surrounding tissue comprises adventitia.
17. The method of Claim 15, wherein turning comprises relaxation of a pre-formed configuration in the device.
18. The method of Claim 15, further comprising translating a guide through the device.
19. The method of Claim 18, wherein translating a guide comprises translating the guide into the lumen.
20. The method of Claim 15, further comprising translating a guide into the lumen.
21. The method of Claim 20, wherein translating a guide comprises translating the guide through the device.
22. An access device for accessing a biological lumen comprising:
an introduction device having a relaxed configuration comprising a first flat section, a first bend at an end of the first flat section, and a first slope extending at a first end from the first bend, the wherein the introduction device is configured to be translated with respect to the access device.
an introduction device having a relaxed configuration comprising a first flat section, a first bend at an end of the first flat section, and a first slope extending at a first end from the first bend, the wherein the introduction device is configured to be translated with respect to the access device.
23. The device of Claim 22, wherein the relaxed configuration of the introduction device further comprises a second bend at a second end of the first slope, a second flat section extending at a first end from the second bend, a third bend at a second end of the second flat section, and a second slope extending from the third bend.
24. The device of Claim 23, further comprising a delivery guide, wherein the delivery guide is configured to deliver the introduction device.
25. The device of Claim 24, further comprising an anchor, wherein the anchor extends from the delivery guide, and wherein the anchor is configured to stabilize the access device with respect to the lumen.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68038805P | 2005-05-12 | 2005-05-12 | |
US60/680,388 | 2005-05-12 | ||
PCT/US2006/018915 WO2006124896A2 (en) | 2005-05-12 | 2006-05-12 | Access and closure device and method |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2607387A1 true CA2607387A1 (en) | 2006-11-23 |
CA2607387C CA2607387C (en) | 2014-12-23 |
Family
ID=37432036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2607387A Expired - Fee Related CA2607387C (en) | 2005-05-12 | 2006-05-12 | Access and closure device and method |
Country Status (8)
Country | Link |
---|---|
US (4) | US8241325B2 (en) |
EP (1) | EP1885260A4 (en) |
JP (2) | JP5140800B2 (en) |
CN (2) | CN101217916B (en) |
AU (1) | AU2006247355B2 (en) |
CA (1) | CA2607387C (en) |
IL (1) | IL187109A0 (en) |
WO (1) | WO2006124896A2 (en) |
Families Citing this family (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060004438A1 (en) * | 2004-04-30 | 2006-01-05 | Novostent Corporation | Prosthesis, delivery system and method for neurovascular aneurysm repair |
US20050267520A1 (en) | 2004-05-12 | 2005-12-01 | Modesitt D B | Access and closure device and method |
US7678133B2 (en) | 2004-07-10 | 2010-03-16 | Arstasis, Inc. | Biological tissue closure device and method |
CN101217916B (en) | 2005-05-12 | 2013-04-10 | 阿尔斯塔西斯公司 | Access and closure device and method |
AU2006262287A1 (en) | 2005-06-21 | 2007-01-04 | Cardiomems, Inc. | Method of manufacturing implantable wireless sensor for in vivo pressure measurement |
US11020141B2 (en) | 2005-09-12 | 2021-06-01 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US8083727B2 (en) | 2005-09-12 | 2011-12-27 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US7938819B2 (en) | 2005-09-12 | 2011-05-10 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US7918870B2 (en) | 2005-09-12 | 2011-04-05 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
EP1924315B1 (en) | 2005-09-12 | 2019-12-04 | Bridgepoint Medical, Inc. | Endovascular devices |
US10888354B2 (en) | 2006-11-21 | 2021-01-12 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US9060802B2 (en) | 2006-11-21 | 2015-06-23 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US11298511B2 (en) | 2006-11-21 | 2022-04-12 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US8894582B2 (en) * | 2007-01-26 | 2014-11-25 | Endotronix, Inc. | Cardiac pressure monitoring device |
US8570186B2 (en) | 2011-04-25 | 2013-10-29 | Endotronix, Inc. | Wireless sensor reader |
US8154389B2 (en) | 2007-03-15 | 2012-04-10 | Endotronix, Inc. | Wireless sensor reader |
US8493187B2 (en) | 2007-03-15 | 2013-07-23 | Endotronix, Inc. | Wireless sensor reader |
US10003862B2 (en) | 2007-03-15 | 2018-06-19 | Endotronix, Inc. | Wireless sensor reader |
US20080281212A1 (en) * | 2007-03-15 | 2008-11-13 | Nunez Anthony I | Transseptal monitoring device |
WO2008152617A2 (en) | 2007-06-15 | 2008-12-18 | Zerusa Limited | A closure device |
US20090024042A1 (en) * | 2007-07-03 | 2009-01-22 | Endotronix, Inc. | Method and system for monitoring ventricular function of a heart |
EP3659664A1 (en) | 2007-10-22 | 2020-06-03 | Bridgepoint Medical, Inc. | Devices for crossing chronic total occlusions |
US8337425B2 (en) | 2008-02-05 | 2012-12-25 | Bridgepoint Medical, Inc. | Endovascular device with a tissue piercing distal probe and associated methods |
EP2259830B1 (en) | 2008-02-05 | 2017-08-16 | Bridgepoint Medical, Inc. | Crossing occlusions in blood vessels |
EP2291128B1 (en) | 2008-04-28 | 2016-08-31 | Bridgepoint Medical, Inc. | Apparatus for crossing occlusions in blood vessels |
JP2011528606A (en) * | 2008-07-21 | 2011-11-24 | アルスタシス,インコーポレイテッド | Apparatus and method for forming a tract in tissue |
JP2011528605A (en) * | 2008-07-21 | 2011-11-24 | アルスタシス,インコーポレイテッド | Device, method, and kit for forming a tube in tissue |
WO2010011956A1 (en) * | 2008-07-25 | 2010-01-28 | Spine View, Inc. | Systems and methods for cable-based debriders |
US8309772B2 (en) | 2008-07-31 | 2012-11-13 | Celanese International Corporation | Tunable catalyst gas phase hydrogenation of carboxylic acids |
US8637714B2 (en) | 2008-07-31 | 2014-01-28 | Celanese International Corporation | Process for producing ethanol over catalysts containing platinum and palladium |
US8309773B2 (en) | 2010-02-02 | 2012-11-13 | Calanese International Corporation | Process for recovering ethanol |
US9168047B2 (en) * | 2009-04-02 | 2015-10-27 | John T. To | Minimally invasive discectomy |
US8801739B2 (en) | 2009-04-17 | 2014-08-12 | Spine View, Inc. | Devices and methods for arched roof cutters |
WO2010132835A1 (en) * | 2009-05-15 | 2010-11-18 | Arstasis, Inc. | Devices, methods and kits for forming tracts in tissue |
AU2010298315A1 (en) * | 2009-09-22 | 2012-04-19 | Arstasis, Inc. | Devices, methods, and kits for forming tracts in tissue |
BR112012017771B1 (en) | 2009-12-23 | 2020-07-14 | Alcon Research, Llc | VALVE TROCART CANNULA |
US8343106B2 (en) | 2009-12-23 | 2013-01-01 | Alcon Research, Ltd. | Ophthalmic valved trocar vent |
US11357486B2 (en) | 2009-12-30 | 2022-06-14 | Vivasure Medical Limited | Closure system and uses thereof |
AU2011203850A1 (en) * | 2010-01-11 | 2012-08-02 | Arstasis, Inc. | Device for forming tracts in tissue |
US8211821B2 (en) | 2010-02-01 | 2012-07-03 | Celanese International Corporation | Processes for making tin-containing catalysts |
US8575403B2 (en) | 2010-05-07 | 2013-11-05 | Celanese International Corporation | Hydrolysis of ethyl acetate in ethanol separation process |
US8932372B2 (en) | 2010-02-02 | 2015-01-13 | Celanese International Corporation | Integrated process for producing alcohols from a mixed acid feed |
US8460405B2 (en) | 2010-02-02 | 2013-06-11 | Celanese International Corporation | Ethanol compositions |
US8747492B2 (en) | 2010-02-02 | 2014-06-10 | Celanese International Corporation | Ethanol/fuel blends for use as motor fuels |
US8541633B2 (en) | 2010-02-02 | 2013-09-24 | Celanese International Corporation | Processes for producing anhydrous ethanol compositions |
US8222466B2 (en) | 2010-02-02 | 2012-07-17 | Celanese International Corporation | Process for producing a water stream from ethanol production |
US8344186B2 (en) | 2010-02-02 | 2013-01-01 | Celanese International Corporation | Processes for producing ethanol from acetaldehyde |
US8754267B2 (en) | 2010-05-07 | 2014-06-17 | Celanese International Corporation | Process for separating acetaldehyde from ethanol-containing mixtures |
US9272970B2 (en) | 2010-07-09 | 2016-03-01 | Celanese International Corporation | Hydrogenolysis of ethyl acetate in alcohol separation processes |
WO2012006499A2 (en) | 2010-07-09 | 2012-01-12 | Celanese International Corporation | Finishing reactor for purifying ethanol |
US20120022562A1 (en) * | 2010-07-23 | 2012-01-26 | Boston Scientific Scimed, Inc. | Device to detect internal bleeding |
US9428254B1 (en) | 2010-09-24 | 2016-08-30 | Katalyst Surgical, Llc | Microsurgical handle and instrument |
US8907141B2 (en) | 2011-04-26 | 2014-12-09 | Celanese International Corporation | Process to recover alcohol with secondary reactors for esterification of acid |
US8927788B2 (en) | 2011-04-26 | 2015-01-06 | Celanese International Corporation | Process to recover alcohol with reduced water from overhead of acid column |
US8927784B2 (en) | 2011-04-26 | 2015-01-06 | Celanese International Corporation | Process to recover alcohol from an ethyl acetate residue stream |
US9000233B2 (en) | 2011-04-26 | 2015-04-07 | Celanese International Corporation | Process to recover alcohol with secondary reactors for hydrolysis of acetal |
US9024084B2 (en) | 2011-04-26 | 2015-05-05 | Celanese International Corporation | Reduced energy alcohol separation process having controlled pressure |
US8884081B2 (en) | 2011-04-26 | 2014-11-11 | Celanese International Corporation | Integrated process for producing acetic acid and alcohol |
US8754268B2 (en) | 2011-04-26 | 2014-06-17 | Celanese International Corporation | Process for removing water from alcohol mixtures |
US8686199B2 (en) | 2011-04-26 | 2014-04-01 | Celanese International Corporation | Process for reducing the concentration of acetic acid in a crude alcohol product |
WO2014070316A1 (en) | 2012-09-14 | 2014-05-08 | Endotronix, Inc. | Pressure sensor, anchor, delivery system and method |
US8748676B2 (en) | 2011-08-03 | 2014-06-10 | Celanese International Corporation | Process for purifying a crude ethanol product |
US8884079B2 (en) | 2011-08-03 | 2014-11-11 | Celanese International Corporation | Reducing impurities in hydrogenation processes with multiple reaction zones |
US8575405B2 (en) | 2011-08-03 | 2013-11-05 | Celanese International Corporation | Reducing acetals during ethanol separation process |
US8895786B2 (en) | 2011-08-03 | 2014-11-25 | Celanese International Corporation | Processes for increasing alcohol production |
US8821444B2 (en) | 2011-10-03 | 2014-09-02 | Katalyst Surgical, Llc | Multi-utility surgical instrument |
US8658843B2 (en) | 2011-10-06 | 2014-02-25 | Celanese International Corporation | Hydrogenation catalysts prepared from polyoxometalate precursors and process for using same to produce ethanol while minimizing diethyl ether formation |
US8536382B2 (en) | 2011-10-06 | 2013-09-17 | Celanese International Corporation | Processes for hydrogenating alkanoic acids using catalyst comprising tungsten |
WO2013081691A1 (en) | 2011-12-03 | 2013-06-06 | Ouroboros Medical, Inc. | Safe cutting heads and systems for fast removal of a target tissue |
US9138346B2 (en) | 2012-01-26 | 2015-09-22 | Katalyst Surgical, Llc | Surgical instrument sleeve |
US8729311B2 (en) | 2012-02-10 | 2014-05-20 | Celanese International Corporaton | Catalysts for converting acetic acid to acetone |
US9737286B2 (en) | 2012-02-29 | 2017-08-22 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US8802903B2 (en) | 2012-03-13 | 2014-08-12 | Celanese International Corporation | Stacked bed reactor with diluents for producing ethanol |
US20130317481A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
US20130317438A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
EP2879599B1 (en) * | 2012-08-01 | 2020-04-29 | Arstasis, Inc. | Access closure configuration |
US20140039546A1 (en) * | 2012-08-01 | 2014-02-06 | Arstasis Inc. | Access closure configuration |
WO2014045331A1 (en) * | 2012-09-18 | 2014-03-27 | テルモ株式会社 | Puncturing tool and puncturing-tool assembly |
US9629645B2 (en) | 2012-10-30 | 2017-04-25 | Katalyst Surgical, Llc | Atraumatic microsurgical forceps |
US9226762B2 (en) * | 2012-11-07 | 2016-01-05 | Katalyst Surgical, Llc | Atraumatic microsurgical forceps |
US9554785B2 (en) | 2012-12-21 | 2017-01-31 | Essential Medical, Inc. | Vascular locating systems and methods of use |
US9131931B2 (en) | 2013-01-21 | 2015-09-15 | Vi Bravoseal, Llc | Vessel sealing device with automatic deployment |
US10307145B2 (en) | 2013-01-21 | 2019-06-04 | Cyndrx, Llc | Vessel sealing device |
US11253242B2 (en) | 2013-01-21 | 2022-02-22 | Cyndrx, Llc | Vessel sealing device |
US9138215B2 (en) | 2013-01-21 | 2015-09-22 | Vi Bravoseal, Llc | Vessel sealing device |
US20140277111A1 (en) * | 2013-03-12 | 2014-09-18 | St. Jude Medical Puerto Rico Llc | Oval vascular closure device and methods |
US9850013B2 (en) | 2013-03-15 | 2017-12-26 | Vivasure Medical Limited | Loading devices and methods for percutaneous perforation closure systems |
WO2015009763A1 (en) | 2013-07-19 | 2015-01-22 | Ouroboros Medical, Inc. | An anti-clogging device for a vacuum-assisted, tissue removal system |
CN105517625A (en) * | 2013-09-06 | 2016-04-20 | 波士顿科学神经调制公司 | Lead introducer for implantable electrical stimulation system |
CN103706017B (en) * | 2013-12-27 | 2016-08-17 | 先健科技(深圳)有限公司 | adjustable bending sheath tube |
US10022267B2 (en) | 2014-04-21 | 2018-07-17 | Katalyst Surgical, Llc | Method of manufacturing a microsurgical instrument tip |
US9775943B2 (en) | 2014-10-10 | 2017-10-03 | Katalyst Surgical, Llc | Cannula ingress system |
EP3232939B1 (en) | 2014-12-15 | 2020-09-23 | Vivasure Medical Limited | Implantable sealable member with mesh layer |
WO2016096932A1 (en) | 2014-12-15 | 2016-06-23 | Vivasure Medical Limited | Closure apparatus with flexible sealable member and flexible support member |
US10080571B2 (en) | 2015-03-06 | 2018-09-25 | Warsaw Orthopedic, Inc. | Surgical instrument and method |
US9996712B2 (en) | 2015-09-02 | 2018-06-12 | Endotronix, Inc. | Self test device and method for wireless sensor reader |
WO2017102941A1 (en) | 2015-12-15 | 2017-06-22 | Vivasure Medical Limited | Arteriotomy closure apparatus with slotted shoe for advantageous pressure distribution |
US11160935B2 (en) | 2016-06-16 | 2021-11-02 | Katalyst Surgical, Llc | Reusable instrument handle with single-use tip |
US10695043B2 (en) | 2017-02-21 | 2020-06-30 | Katalyst Surgical, Llc | Surgical instrument subcomponent integration by additive manufacturing |
US11615257B2 (en) | 2017-02-24 | 2023-03-28 | Endotronix, Inc. | Method for communicating with implant devices |
CA3053497A1 (en) | 2017-02-24 | 2018-08-30 | Endotronix, Inc. | Wireless sensor reader assembly |
CA3062861A1 (en) | 2017-04-20 | 2018-10-25 | Endotronix, Inc. | Anchoring system for a catheter delivered device |
US10849640B2 (en) | 2018-05-23 | 2020-12-01 | Katalyst Surgical, Llc | Membrane aggregating forceps |
WO2023043661A1 (en) * | 2021-09-17 | 2023-03-23 | Teleflex Life Sciences Limited | Depth gauge system |
Family Cites Families (262)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2857925A (en) * | 1954-10-01 | 1958-10-28 | Higginbotham Richard Stopford | Ground gripping ferrule for use on walking sticks, crutches and the like |
US3727614A (en) * | 1971-05-13 | 1973-04-17 | Merck & Co Inc | Multiple dosage inoculator |
US3730185A (en) | 1971-10-29 | 1973-05-01 | Cook Inc | Endarterectomy apparatus |
US4006747A (en) | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4774949A (en) | 1983-06-14 | 1988-10-04 | Fogarty Thomas J | Deflector guiding catheter |
US4744364A (en) | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4850960A (en) * | 1987-07-08 | 1989-07-25 | Joseph Grayzel | Diagonally tapered, bevelled tip introducing catheter and sheath and method for insertion |
US4890611A (en) | 1988-04-05 | 1990-01-02 | Thomas J. Fogarty | Endarterectomy apparatus and method |
US4921484A (en) * | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
US4955897A (en) * | 1988-08-22 | 1990-09-11 | Ship Arthur G | Tissue forceps |
US5620461A (en) | 1989-05-29 | 1997-04-15 | Muijs Van De Moer; Wouter M. | Sealing device |
US4962755A (en) * | 1989-07-21 | 1990-10-16 | Heart Tech Of Minnesota, Inc. | Method for performing endarterectomy |
US5571169A (en) | 1993-06-07 | 1996-11-05 | Endovascular Instruments, Inc. | Anti-stenotic method and product for occluded and partially occluded arteries |
US5662701A (en) | 1989-08-18 | 1997-09-02 | Endovascular Instruments, Inc. | Anti-stenotic method and product for occluded and partially occluded arteries |
NL9000487A (en) | 1990-03-01 | 1991-10-01 | Advanced Protective Injection | PROTECTION ASSEMBLY FOR AN INJECTION SYRINGE. |
US5391183A (en) | 1990-09-21 | 1995-02-21 | Datascope Investment Corp | Device and method sealing puncture wounds |
US5183464A (en) | 1991-05-17 | 1993-02-02 | Interventional Thermodynamics, Inc. | Radially expandable dilator |
US5358507A (en) | 1991-07-26 | 1994-10-25 | Pat O. Daily | Thromboendarterectomy suction dissector |
US6818008B1 (en) | 1992-01-07 | 2004-11-16 | Cch Associates, Inc. | Percutaneous puncture sealing method |
US5271415A (en) | 1992-01-28 | 1993-12-21 | Baxter International Inc. | Guidewire extension system |
US5993389A (en) | 1995-05-22 | 1999-11-30 | Ths International, Inc. | Devices for providing acoustic hemostasis |
WO1993016641A1 (en) | 1992-02-21 | 1993-09-02 | Diasonics, Inc. | Ultrasound intracavity system for imaging therapy planning and treatment of focal disease |
US5380290A (en) * | 1992-04-16 | 1995-01-10 | Pfizer Hospital Products Group, Inc. | Body access device |
US6063085A (en) | 1992-04-23 | 2000-05-16 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
CA2134071C (en) * | 1992-04-23 | 1999-04-27 | Sew Wah Tay | Apparatus and method for sealing vascular punctures |
US5810810A (en) * | 1992-04-23 | 1998-09-22 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
US5368601A (en) | 1992-04-30 | 1994-11-29 | Lasersurge, Inc. | Trocar wound closure device |
CA2106127A1 (en) | 1992-09-23 | 1994-03-24 | Peter W.J. Hinchliffe | Instrument for closing trocar puncture wounds |
US5489288A (en) | 1992-10-09 | 1996-02-06 | Advanced Surgical, Inc. | Device and method for applying large-diameter ligating loop |
US6398782B1 (en) | 1992-10-13 | 2002-06-04 | Edwards Lifesciences Corporation | Bipolar vascular sealing apparatus and methods |
US5415657A (en) | 1992-10-13 | 1995-05-16 | Taymor-Luria; Howard | Percutaneous vascular sealing method |
US5336221A (en) * | 1992-10-14 | 1994-08-09 | Premier Laser Systems, Inc. | Method and apparatus for applying thermal energy to tissue using a clamp |
US5383897A (en) * | 1992-10-19 | 1995-01-24 | Shadyside Hospital | Method and apparatus for closing blood vessel punctures |
US5304184A (en) | 1992-10-19 | 1994-04-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5364389A (en) * | 1992-11-25 | 1994-11-15 | Premier Laser Systems, Inc. | Method and apparatus for sealing and/or grasping luminal tissue |
US5417699A (en) | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5467786A (en) | 1992-12-10 | 1995-11-21 | William C. Allen | Method for repairing tears and incisions in soft tissue |
US6036699A (en) | 1992-12-10 | 2000-03-14 | Perclose, Inc. | Device and method for suturing tissue |
DE4310555C1 (en) | 1993-03-31 | 1993-12-09 | Strobel & Soehne Gmbh & Co J | Surgical machine stitching tissue edges together - has forceps opening and shutting in synchronism with needle to hold edges together before puncturing |
US5503634A (en) | 1993-04-28 | 1996-04-02 | Christy; William J. | Surgical stab wound closure device and method |
ES2123019T3 (en) * | 1993-06-24 | 1999-01-01 | Schneider Europ Gmbh | ASPIRATION CATHETER. |
US5527321A (en) | 1993-07-14 | 1996-06-18 | United States Surgical Corporation | Instrument for closing trocar puncture wounds |
US5391182A (en) | 1993-08-03 | 1995-02-21 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5462561A (en) | 1993-08-05 | 1995-10-31 | Voda; Jan K. | Suture device |
US5474568A (en) | 1993-10-08 | 1995-12-12 | United States Surgical Corporation | Instrument for closing trocar puncture wounds |
US5470338A (en) | 1993-10-08 | 1995-11-28 | United States Surgical Corporation | Instrument for closing trocar puncture wounds |
US5437665A (en) * | 1993-10-12 | 1995-08-01 | Munro; Malcolm G. | Electrosurgical loop electrode instrument for laparoscopic surgery |
US5439469A (en) | 1993-11-05 | 1995-08-08 | Advanced Surgical, Inc. | Wound closure device |
US5527322A (en) * | 1993-11-08 | 1996-06-18 | Perclose, Inc. | Device and method for suturing of internal puncture sites |
US5476470A (en) | 1994-04-15 | 1995-12-19 | Fitzgibbons, Jr.; Robert J. | Trocar site suturing device |
WO1995032669A1 (en) | 1994-06-01 | 1995-12-07 | Perclose, Inc. | Apparatus and method for advancing surgical knots |
WO1995032671A1 (en) * | 1994-06-01 | 1995-12-07 | Perclose, Inc. | Method and device for providing vascular hemostasis |
US6302898B1 (en) | 1994-06-24 | 2001-10-16 | Advanced Closure Systems, Inc. | Devices for sealing punctures in body vessels |
US6033401A (en) | 1997-03-12 | 2000-03-07 | Advanced Closure Systems, Inc. | Vascular sealing device with microwave antenna |
US5582616A (en) * | 1994-08-05 | 1996-12-10 | Origin Medsystems, Inc. | Surgical helical fastener with applicator |
US5536255A (en) * | 1994-10-03 | 1996-07-16 | Moss; Gerald | Dilator/introducer apparatus for percutaneous gastrostomy |
US5451230A (en) | 1994-10-11 | 1995-09-19 | Steinert; Roger F. | Cataract disassembly |
US5496332A (en) | 1994-10-20 | 1996-03-05 | Cordis Corporation | Wound closure apparatus and method for its use |
US5695504A (en) | 1995-02-24 | 1997-12-09 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
DE69622969T2 (en) | 1995-06-07 | 2003-04-24 | Medtronic Inc | WOUND CLOSURE DEVICE |
US6132438A (en) | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US5709224A (en) * | 1995-06-07 | 1998-01-20 | Radiotherapeutics Corporation | Method and device for permanent vessel occlusion |
US5902311A (en) * | 1995-06-15 | 1999-05-11 | Perclose, Inc. | Low profile intraluminal suturing device and method |
US5846253A (en) | 1995-07-14 | 1998-12-08 | C. R. Bard, Inc. | Wound closure apparatus and method |
US5700273A (en) | 1995-07-14 | 1997-12-23 | C.R. Bard, Inc. | Wound closure apparatus and method |
WO1997007745A1 (en) | 1995-08-24 | 1997-03-06 | Nobles-Lai Engineering, Inc. | Method and apparatus for suturing |
US6117144A (en) | 1995-08-24 | 2000-09-12 | Sutura, Inc. | Suturing device and method for sealing an opening in a blood vessel or other biological structure |
US5653717A (en) | 1995-08-28 | 1997-08-05 | Urohealth Systems, Inc. | Wound closure device |
US5645566A (en) | 1995-09-15 | 1997-07-08 | Sub Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6071300A (en) * | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US5830222A (en) | 1995-10-13 | 1998-11-03 | Transvascular, Inc. | Device, system and method for intersititial transvascular intervention |
US6302875B1 (en) | 1996-10-11 | 2001-10-16 | Transvascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
US6524326B1 (en) * | 1995-12-07 | 2003-02-25 | Loma Linda University Medical Center | Tissue opening locator and everter and method |
US5772673A (en) * | 1996-03-07 | 1998-06-30 | United States Surgical Corporation | Apparatus for applying surgical clips |
US6152918A (en) * | 1996-04-05 | 2000-11-28 | Eclipse Surgical Technologies, Inc. | Laser device with auto-piercing tip for myocardial revascularization procedures |
US6468228B1 (en) * | 1996-06-18 | 2002-10-22 | Vance Products Incorporated | Surgical tissue morcellator |
US5954713A (en) | 1996-07-12 | 1999-09-21 | Newman; Fredric A. | Endarterectomy surgical instruments and procedure |
US5989276A (en) * | 1996-11-08 | 1999-11-23 | Advanced Bypass Technologies, Inc. | Percutaneous bypass graft and securing system |
US5766183A (en) | 1996-10-21 | 1998-06-16 | Lasersurge, Inc. | Vascular hole closure |
EP1459692A1 (en) | 1996-10-23 | 2004-09-22 | Oratec Interventions, Inc. | Method and apparatus for treating intervertebral discs |
US5758665A (en) * | 1996-11-14 | 1998-06-02 | Suval; William D. | Method for treating varicose veins |
US6036721A (en) * | 1996-11-16 | 2000-03-14 | Cap Incorporated | Puncture closure |
US5782861A (en) | 1996-12-23 | 1998-07-21 | Sub Q Inc. | Percutaneous hemostasis device |
US6371975B2 (en) | 1998-11-06 | 2002-04-16 | Neomend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
US6733515B1 (en) * | 1997-03-12 | 2004-05-11 | Neomend, Inc. | Universal introducer |
US6475182B1 (en) | 1997-03-12 | 2002-11-05 | Olexander Hnojewyj | Fluidic media introduction apparatus |
AU744343B2 (en) | 1997-04-11 | 2002-02-21 | Transvascular, Inc. | Methods and apparatus for transmyocardial direct coronary revascularization |
US5984948A (en) | 1997-04-14 | 1999-11-16 | Hasson; Harrith M. | Device for closing an opening in tissue and method of closing a tissue opening using the device |
US5830232A (en) | 1997-04-14 | 1998-11-03 | Hasson; Harrith M. | Device for closing an opening in tissue and method of closing a tissue opening using the device |
US5941897A (en) | 1997-05-09 | 1999-08-24 | Myers; Gene E. | Energy activated fibrin plug |
US6071292A (en) | 1997-06-28 | 2000-06-06 | Transvascular, Inc. | Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures |
EP0895753A1 (en) | 1997-07-31 | 1999-02-10 | Academisch Ziekenhuis Utrecht | Temporary vascular seal for anastomosis |
US5954732A (en) | 1997-09-10 | 1999-09-21 | Hart; Charles C. | Suturing apparatus and method |
US6179832B1 (en) * | 1997-09-11 | 2001-01-30 | Vnus Medical Technologies, Inc. | Expandable catheter having two sets of electrodes |
US6258084B1 (en) * | 1997-09-11 | 2001-07-10 | Vnus Medical Technologies, Inc. | Method for applying energy to biological tissue including the use of tumescent tissue compression |
US5972013A (en) * | 1997-09-19 | 1999-10-26 | Comedicus Incorporated | Direct pericardial access device with deflecting mechanism and method |
US6592552B1 (en) | 1997-09-19 | 2003-07-15 | Cecil C. Schmidt | Direct pericardial access device and method |
US5868762A (en) | 1997-09-25 | 1999-02-09 | Sub-Q, Inc. | Percutaneous hemostatic suturing device and method |
US5928246A (en) * | 1997-10-15 | 1999-07-27 | Bsc Northwest Technology Center, Inc. | Stent securing catheter |
US6139556A (en) * | 1997-10-29 | 2000-10-31 | X-Site, L.L.C. | Device and method for suturing blood vessels and the like |
US6159232A (en) | 1997-12-16 | 2000-12-12 | Closys Corporation | Clotting cascade initiating apparatus and methods of use and methods of closing wounds |
US5972005A (en) | 1998-02-17 | 1999-10-26 | Advanced Cardiovascular Systems, Ind. | Wound closure assembly and method of use |
US6010514A (en) * | 1998-03-17 | 2000-01-04 | Burney; Bryan T. | Suturing assembly and method of use |
US6042601A (en) | 1998-03-18 | 2000-03-28 | United States Surgical Corporation | Apparatus for vascular hole closure |
US20010045575A1 (en) | 1998-05-01 | 2001-11-29 | Mark Ashby | Device and method for facilitating hemostasis of a biopsy tract |
US5980539A (en) | 1998-05-06 | 1999-11-09 | X-Site L.L.C. | Device and method for suturing blood vessels and the like |
US6936053B1 (en) | 1998-07-02 | 2005-08-30 | Jeffrey N. Weiss | Ocular implant needle |
US6080175A (en) * | 1998-07-29 | 2000-06-27 | Corvascular, Inc. | Surgical cutting instrument and method of use |
US7790192B2 (en) * | 1998-08-14 | 2010-09-07 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US6143004A (en) | 1998-08-18 | 2000-11-07 | Atrion Medical Products, Inc. | Suturing device |
US6458147B1 (en) | 1998-11-06 | 2002-10-01 | Neomend, Inc. | Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue |
US6994686B2 (en) | 1998-08-26 | 2006-02-07 | Neomend, Inc. | Systems for applying cross-linked mechanical barriers |
US6093173A (en) * | 1998-09-09 | 2000-07-25 | Embol-X, Inc. | Introducer/dilator with balloon protection and methods of use |
AU6384699A (en) | 1998-09-10 | 2000-04-03 | Percardia, Inc. | Tmr shunt |
US7279001B2 (en) | 1998-11-06 | 2007-10-09 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US6949114B2 (en) | 1998-11-06 | 2005-09-27 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US6371963B1 (en) * | 1998-11-17 | 2002-04-16 | Scimed Life Systems, Inc. | Device for controlled endoscopic penetration of injection needle |
US6592559B1 (en) * | 1998-12-09 | 2003-07-15 | Cook Incorporated | Hollow, curved, superlastic medical needle |
US6248124B1 (en) * | 1999-02-22 | 2001-06-19 | Tyco Healthcare Group | Arterial hole closure apparatus |
US7001400B1 (en) * | 1999-03-04 | 2006-02-21 | Abbott Laboratories | Articulating suturing device and method |
US7235087B2 (en) * | 1999-03-04 | 2007-06-26 | Abbott Park | Articulating suturing device and method |
US6136010A (en) * | 1999-03-04 | 2000-10-24 | Perclose, Inc. | Articulating suturing device and method |
US6964668B2 (en) * | 1999-03-04 | 2005-11-15 | Abbott Laboratories | Articulating suturing device and method |
US20040092964A1 (en) * | 1999-03-04 | 2004-05-13 | Modesitt D. Bruce | Articulating suturing device and method |
US6139560A (en) * | 1999-03-16 | 2000-10-31 | Kremer; Frederic B. | Cutting device and method for making controlled surgical incisions |
US6981983B1 (en) | 1999-03-31 | 2006-01-03 | Rosenblatt Peter L | System and methods for soft tissue reconstruction |
US6146397A (en) | 1999-04-06 | 2000-11-14 | Harkrider, Jr.; William W. | Endarterectomy loop |
US7226467B2 (en) * | 1999-04-09 | 2007-06-05 | Evalve, Inc. | Fixation device delivery catheter, systems and methods of use |
US20040044350A1 (en) * | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
USRE44297E1 (en) | 1999-06-18 | 2013-06-11 | Radi Medical Systems Ab | Tool, a sealing device, a system and a method for closing a wound |
US7955340B2 (en) * | 1999-06-25 | 2011-06-07 | Usgi Medical, Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US6565583B1 (en) | 1999-07-08 | 2003-05-20 | Acumen Vascular, Inc. | Endarterectomy apparatus and method |
US6206895B1 (en) | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
AU7373700A (en) | 1999-09-13 | 2001-04-17 | Rex Medical, Lp | Vascular closure |
US7341595B2 (en) | 1999-09-13 | 2008-03-11 | Rex Medical, L.P | Vascular hole closure device |
US6171317B1 (en) | 1999-09-14 | 2001-01-09 | Perclose, Inc. | Knot tying device and method |
US6190396B1 (en) | 1999-09-14 | 2001-02-20 | Perclose, Inc. | Device and method for deploying and organizing sutures for anastomotic and other attachments |
US6423051B1 (en) | 1999-09-16 | 2002-07-23 | Aaron V. Kaplan | Methods and apparatus for pericardial access |
CA2387127A1 (en) | 1999-10-25 | 2001-05-17 | Therus Corporation | Use of focused ultrasound for vascular sealing |
AU1464401A (en) | 1999-11-05 | 2001-06-06 | Onux Medical, Inc. | Apparatus and method for approximating and closing the walls of a hole or puncture in a physiological shell structure |
US6641592B1 (en) | 1999-11-19 | 2003-11-04 | Lsi Solutions, Inc. | System for wound closure |
US6203554B1 (en) | 1999-11-23 | 2001-03-20 | William Roberts | Apparatus, kit and methods for puncture site closure |
US6626855B1 (en) * | 1999-11-26 | 2003-09-30 | Therus Corpoation | Controlled high efficiency lesion formation using high intensity ultrasound |
AU2598201A (en) * | 1999-12-23 | 2001-07-03 | Therus Corporation | Ultrasound transducers for imaging and therapy |
US6942674B2 (en) | 2000-01-05 | 2005-09-13 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a closure device |
US6197042B1 (en) | 2000-01-05 | 2001-03-06 | Medical Technology Group, Inc. | Vascular sheath with puncture site closure apparatus and methods of use |
US6780197B2 (en) | 2000-01-05 | 2004-08-24 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a vascular closure device to a body lumen |
US7077848B1 (en) | 2000-03-11 | 2006-07-18 | John Hopkins University | Sutureless occular surgical methods and instruments for use in such methods |
US6802822B1 (en) | 2000-03-31 | 2004-10-12 | 3M Innovative Properties Company | Dispenser for an adhesive tissue sealant having a flexible link |
US6533795B1 (en) | 2000-04-11 | 2003-03-18 | Opus Medical, Inc | Dual function suturing apparatus and method |
US7083628B2 (en) | 2002-09-03 | 2006-08-01 | Edwards Lifesciences Corporation | Single catheter mitral valve repair device and method for use |
DE10026172A1 (en) | 2000-05-26 | 2001-11-29 | Roche Diagnostics Gmbh | Body fluid withdrawal system |
US6846321B2 (en) | 2000-06-21 | 2005-01-25 | Cardiodex, Ltd. | Mechanical method and apparatus for enhancing hemostatis following arterial catheterization |
AU2001273401A1 (en) | 2000-07-14 | 2002-01-30 | Sub-Q Inc. | Sheath-mounted arterial plug delivery device |
US6890342B2 (en) | 2000-08-02 | 2005-05-10 | Loma Linda University | Method and apparatus for closing vascular puncture using hemostatic material |
DE60135352D1 (en) | 2000-08-30 | 2008-09-25 | Univ Johns Hopkins | DEVICE FOR INTRA-OCCULAR ACTIVE AGGREGATION |
US6767356B2 (en) | 2000-09-01 | 2004-07-27 | Angiolink Corporation | Advanced wound site management systems and methods |
US20040093024A1 (en) * | 2000-09-01 | 2004-05-13 | James Lousararian | Advanced wound site management systems and methods |
AU2000274774A1 (en) | 2000-09-01 | 2002-03-22 | Angiolink Corporation | Wound site management and wound closure device |
US7074232B2 (en) | 2000-09-01 | 2006-07-11 | Medtronic Angiolink, Inc. | Advanced wound site management systems and methods |
US7029481B1 (en) * | 2000-11-06 | 2006-04-18 | Abbott Laboratories | Systems, devices and methods for suturing patient tissue |
DE60143909D1 (en) * | 2000-11-28 | 2011-03-03 | Intuitive Surgical Operations | Z AND VASCULAR CLOSURE |
US6695867B2 (en) * | 2002-02-21 | 2004-02-24 | Integrated Vascular Systems, Inc. | Plunger apparatus and methods for delivering a closure device |
US6623510B2 (en) | 2000-12-07 | 2003-09-23 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US6840952B2 (en) | 2000-12-07 | 2005-01-11 | Mark B. Saker | Tissue tract sealing device |
US7905900B2 (en) * | 2003-01-30 | 2011-03-15 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US6896692B2 (en) | 2000-12-14 | 2005-05-24 | Ensure Medical, Inc. | Plug with collet and apparatus and method for delivering such plugs |
US6846319B2 (en) | 2000-12-14 | 2005-01-25 | Core Medical, Inc. | Devices for sealing openings through tissue and apparatus and methods for delivering them |
US6969397B2 (en) | 2000-12-14 | 2005-11-29 | Ensure Medical, Inc. | Guide wire element for positioning vascular closure devices and methods for use |
US6890343B2 (en) | 2000-12-14 | 2005-05-10 | Ensure Medical, Inc. | Plug with detachable guidewire element and methods for use |
US6524321B2 (en) | 2001-01-03 | 2003-02-25 | Nozomu Kanesaka | Closure device for puncture in vessel |
WO2002056144A2 (en) | 2001-01-09 | 2002-07-18 | Topcoder Inc | Systems and methods for coding competitions |
WO2002054941A2 (en) * | 2001-01-11 | 2002-07-18 | Rita Medical Systems Inc | Bone-treatment instrument and method |
DE60205780T2 (en) | 2001-01-12 | 2006-05-18 | Radi Medical Systems Ab | Arterial wall occlusion device provided with a position indicator |
US6454777B1 (en) | 2001-02-27 | 2002-09-24 | David T. Green | Apparatus and method for suturing a blood vessel |
US7041119B2 (en) | 2001-02-27 | 2006-05-09 | Green David T | Apparatus for suturing a blood vessel |
US6743195B2 (en) | 2001-03-14 | 2004-06-01 | Cardiodex | Balloon method and apparatus for vascular closure following arterial catheterization |
US7025776B1 (en) | 2001-04-24 | 2006-04-11 | Advanced Catheter Engineering, Inc. | Arteriotomy closure devices and techniques |
FR2824253B1 (en) | 2001-05-04 | 2005-02-18 | Francis Navarro | INTRUMENT FOR CLOSING BY SUTURE SUBCUTANEOUS AN ORIFICE REALIZED IN THE ABDOMINAL WALL OF A PATIENT |
US6863680B2 (en) | 2001-11-08 | 2005-03-08 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US7008440B2 (en) | 2001-11-08 | 2006-03-07 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US7029489B1 (en) | 2001-05-18 | 2006-04-18 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture site |
AU2002310364B2 (en) | 2001-06-08 | 2006-02-23 | Morris Innovative Research, Inc. | Method and apparatus for sealing access |
US6457182B1 (en) | 2001-06-08 | 2002-10-01 | The United States Of America As Represented By The Secretary Of The Army | Protective glove |
JP4159805B2 (en) | 2001-06-15 | 2008-10-01 | ラディ・メディカル・システムズ・アクチェボラーグ | Pushing mechanism for closing method |
RU2206092C2 (en) * | 2001-08-24 | 2003-06-10 | Хайрок Холдинг Лимитед | Method for in vitro detecting intolerance to nutrient antigen |
US6773699B1 (en) * | 2001-10-09 | 2004-08-10 | Tissue Adhesive Technologies, Inc. | Light energized tissue adhesive conformal patch |
US6939364B1 (en) * | 2001-10-09 | 2005-09-06 | Tissue Adhesive Technologies, Inc. | Composite tissue adhesive |
US6893431B2 (en) | 2001-10-15 | 2005-05-17 | Scimed Life Systems, Inc. | Medical device for delivering patches |
US7037322B1 (en) | 2001-11-08 | 2006-05-02 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture with a staging tube |
US7037323B2 (en) | 2001-11-08 | 2006-05-02 | Sub-Q, Inc. | Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US20030093114A1 (en) | 2001-11-13 | 2003-05-15 | Melvin Levinson | Method for effecting hemostasis |
US7609673B2 (en) | 2002-02-08 | 2009-10-27 | Telefonaktiebolaget Lm Ericsson (Publ) | Packet-based conversational service for a multimedia session in a mobile communications system |
JP4430939B2 (en) | 2001-12-26 | 2010-03-10 | イエール ユニバーシティ | Blood vessel |
US7247162B1 (en) * | 2002-01-14 | 2007-07-24 | Edwards Lifesciences Corporation | Direct access atherectomy devices |
ATE451064T1 (en) * | 2002-01-25 | 2009-12-15 | Terumo Corp | DEVICE FOR CUTTING BLOOD VESSELS |
US7141055B2 (en) | 2002-04-24 | 2006-11-28 | Surgical Connections, Inc. | Resection and anastomosis devices and methods |
US6939363B2 (en) * | 2002-06-12 | 2005-09-06 | Radi Medical Systems Ab | Closure device |
TWI314464B (en) * | 2002-06-24 | 2009-09-11 | Alza Corp | Reusable, spring driven autoinjector |
US7494460B2 (en) * | 2002-08-21 | 2009-02-24 | Medtronic, Inc. | Methods and apparatus providing suction-assisted tissue engagement through a minimally invasive incision |
AU2003276903A1 (en) * | 2002-09-20 | 2004-05-04 | Flowmedica, Inc. | Method and apparatus for selective material delivery via an intra-renal catheter |
US7662128B2 (en) | 2002-12-23 | 2010-02-16 | Salcudean Septimiu E | Steerable needle |
US7008442B2 (en) | 2003-01-20 | 2006-03-07 | Medtronic Vascular, Inc. | Vascular sealant delivery device and sheath introducer and method |
US7322976B2 (en) * | 2003-03-04 | 2008-01-29 | Cardiva Medical, Inc. | Apparatus and methods for closing vascular penetrations |
US7381210B2 (en) | 2003-03-14 | 2008-06-03 | Edwards Lifesciences Corporation | Mitral valve repair system and method for use |
US7186251B2 (en) * | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US6939348B2 (en) * | 2003-03-27 | 2005-09-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US7850654B2 (en) | 2003-04-24 | 2010-12-14 | St. Jude Medical Puerto Rico B.V. | Device and method for positioning a closure device |
US20040220604A1 (en) * | 2003-04-30 | 2004-11-04 | Fogarty Thomas J. | Tissue separation apparatus and method |
US20040220594A1 (en) | 2003-05-02 | 2004-11-04 | Cardio Life Research S.A. | Two-part clamping device |
US9289195B2 (en) | 2003-06-04 | 2016-03-22 | Access Closure, Inc. | Auto-retraction apparatus and methods for sealing a vascular puncture |
US7331979B2 (en) * | 2003-06-04 | 2008-02-19 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
WO2004112615A2 (en) | 2003-06-16 | 2004-12-29 | Galdonik Jason A | Temporary hemostatic plug apparatus and method of use |
US20050049634A1 (en) | 2003-08-07 | 2005-03-03 | Scimed Life Systems, Inc. | Medical closure device |
CA2535452C (en) | 2003-08-14 | 2013-04-02 | Loma Linda University Medical Center | Vascular wound closure device |
US7762977B2 (en) * | 2003-10-08 | 2010-07-27 | Hemosphere, Inc. | Device and method for vascular access |
US8337522B2 (en) | 2003-10-15 | 2012-12-25 | St. Jude Medical Puerto Rico Llc | Vascular sealing device with locking hub |
US7931670B2 (en) | 2003-10-15 | 2011-04-26 | St. Jude Medical Puerto Rico Llc | Tissue puncture closure device with automatic tamping |
US20050085773A1 (en) | 2003-10-15 | 2005-04-21 | Forsberg Andrew T. | Method and apparatus for locating vascular punctures |
US8852229B2 (en) * | 2003-10-17 | 2014-10-07 | Cordis Corporation | Locator and closure device and method of use |
US8007514B2 (en) * | 2003-10-17 | 2011-08-30 | St. Jude Medical Puerto Rico Llc | Automatic suture locking device |
US7361183B2 (en) * | 2003-10-17 | 2008-04-22 | Ensure Medical, Inc. | Locator and delivery device and method of use |
US20050090860A1 (en) | 2003-10-23 | 2005-04-28 | Paprocki Loran J. | Segmented plug for tissue tracts |
EP1691848B1 (en) * | 2003-10-23 | 2012-08-22 | TRANS1, Inc. | Tools and tool kits for performing minimally invasive procedures on the spine |
US20050096697A1 (en) | 2003-11-04 | 2005-05-05 | Forsberg Andrew T. | Vascular insertion sheath with stiffened tip |
US7597705B2 (en) | 2003-12-03 | 2009-10-06 | St. Jude Medical Puerto Rico Llc | Vascular puncture seal anchor nest |
US7731726B2 (en) * | 2003-12-03 | 2010-06-08 | St. Jude Medical Puerto Rico Llc | Suture based vascular closure apparatus and method incorporating a pre-tied knot |
US20050251189A1 (en) | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Multi-position tissue manipulation assembly |
US7361180B2 (en) | 2004-05-07 | 2008-04-22 | Usgi Medical, Inc. | Apparatus for manipulating and securing tissue |
US7390328B2 (en) * | 2003-12-19 | 2008-06-24 | Abbott Laboratories | Device and method for suturing of internal puncture sites |
US20060064101A1 (en) * | 2004-02-12 | 2006-03-23 | Arthrocare Corporation | Bone access system |
JP4700384B2 (en) | 2004-04-07 | 2011-06-15 | オリンパス株式会社 | Medical ligature suturing apparatus and medical ligature suturing system |
US7572274B2 (en) * | 2004-05-27 | 2009-08-11 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
US9017374B2 (en) | 2004-04-09 | 2015-04-28 | Cardiva Medical, Inc. | Device and method for sealing blood vessels |
US7993366B2 (en) | 2004-05-27 | 2011-08-09 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
US20050234507A1 (en) | 2004-04-16 | 2005-10-20 | Jeff Geske | Medical tool for access to internal tissue |
US7390329B2 (en) * | 2004-05-07 | 2008-06-24 | Usgi Medical, Inc. | Methods for grasping and cinching tissue anchors |
US20050267520A1 (en) * | 2004-05-12 | 2005-12-01 | Modesitt D B | Access and closure device and method |
US7678133B2 (en) | 2004-07-10 | 2010-03-16 | Arstasis, Inc. | Biological tissue closure device and method |
WO2006034209A2 (en) * | 2004-09-20 | 2006-03-30 | Suturtek Incorporated | Apparatus and method for minimally invasive suturing |
CA2748617C (en) | 2004-09-27 | 2014-09-23 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US7182763B2 (en) * | 2004-11-23 | 2007-02-27 | Instrasurgical, Llc | Wound closure device |
JP4366306B2 (en) * | 2004-12-17 | 2009-11-18 | テルモ株式会社 | In vivo tissue closure device and in vivo tissue closure device |
US8162905B2 (en) | 2004-12-17 | 2012-04-24 | W. L. Gore & Associates, Inc. | Delivery system |
US20060136035A1 (en) * | 2004-12-20 | 2006-06-22 | Vascular Architects, Inc. A Delaware Corporation | Coiled endoluminal prosthesis system and delivery catheter |
US7470237B2 (en) | 2005-01-10 | 2008-12-30 | Ethicon Endo-Surgery, Inc. | Biopsy instrument with improved needle penetration |
ATE387146T1 (en) * | 2005-01-24 | 2008-03-15 | Ami Gmbh | DEVICE FOR SURGICAL CLOSURE OF A TROCARDIAL THROUGH |
US20060235449A1 (en) | 2005-04-19 | 2006-10-19 | Vascular Architects, Inc., A Delaware Corporation | Vascular intimal lining removal assembly |
US20060259017A1 (en) | 2005-04-27 | 2006-11-16 | Cardiac Pacemakers, Inc. | Adhesive elements and methods for accessing the pericardial space |
CN101217916B (en) | 2005-05-12 | 2013-04-10 | 阿尔斯塔西斯公司 | Access and closure device and method |
US8038687B2 (en) | 2005-05-17 | 2011-10-18 | St. Jude Medical Puerto Rico Llc | Suture loop closure device |
US20070172058A1 (en) * | 2006-01-25 | 2007-07-26 | Tomokazu Sada | Data transmitting apparatus and data receiving apparatus |
US8682411B2 (en) * | 2007-01-22 | 2014-03-25 | Cvdevices, Llc | Devices, systems and methods for epicardial cardiac monitoring system |
US20080097347A1 (en) | 2006-09-22 | 2008-04-24 | Babak Arvanaghi | Bendable needle assembly |
US20080114364A1 (en) * | 2006-11-15 | 2008-05-15 | Aoi Medical, Inc. | Tissue cavitation device and method |
US20090105744A1 (en) * | 2007-10-17 | 2009-04-23 | Modesitt D Bruce | Methods for forming tracts in tissue |
JP2011528605A (en) * | 2008-07-21 | 2011-11-24 | アルスタシス,インコーポレイテッド | Device, method, and kit for forming a tube in tissue |
JP2011528606A (en) * | 2008-07-21 | 2011-11-24 | アルスタシス,インコーポレイテッド | Apparatus and method for forming a tract in tissue |
WO2010132835A1 (en) * | 2009-05-15 | 2010-11-18 | Arstasis, Inc. | Devices, methods and kits for forming tracts in tissue |
AU2010298315A1 (en) * | 2009-09-22 | 2012-04-19 | Arstasis, Inc. | Devices, methods, and kits for forming tracts in tissue |
AU2011203850A1 (en) * | 2010-01-11 | 2012-08-02 | Arstasis, Inc. | Device for forming tracts in tissue |
-
2006
- 2006-05-12 CN CN2006800252468A patent/CN101217916B/en not_active Expired - Fee Related
- 2006-05-12 WO PCT/US2006/018915 patent/WO2006124896A2/en active Application Filing
- 2006-05-12 CN CN2013100756940A patent/CN103190942A/en active Pending
- 2006-05-12 US US11/432,982 patent/US8241325B2/en not_active Expired - Fee Related
- 2006-05-12 EP EP20060770440 patent/EP1885260A4/en not_active Withdrawn
- 2006-05-12 JP JP2008511478A patent/JP5140800B2/en not_active Expired - Fee Related
- 2006-05-12 AU AU2006247355A patent/AU2006247355B2/en not_active Ceased
- 2006-05-12 CA CA2607387A patent/CA2607387C/en not_active Expired - Fee Related
- 2006-10-06 US US11/544,317 patent/US8083767B2/en not_active Expired - Fee Related
-
2007
- 2007-04-19 US US11/788,509 patent/US8002794B2/en not_active Expired - Fee Related
- 2007-11-01 IL IL187109A patent/IL187109A0/en unknown
-
2009
- 2009-05-15 US US12/467,251 patent/US20090318889A1/en not_active Abandoned
-
2010
- 2010-04-26 JP JP2010101185A patent/JP5341816B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1885260A2 (en) | 2008-02-13 |
US8083767B2 (en) | 2011-12-27 |
CN101217916A (en) | 2008-07-09 |
JP2010184124A (en) | 2010-08-26 |
US20060271078A1 (en) | 2006-11-30 |
AU2006247355B2 (en) | 2013-01-10 |
JP5140800B2 (en) | 2013-02-13 |
US20070255313A1 (en) | 2007-11-01 |
IL187109A0 (en) | 2008-02-09 |
CN101217916B (en) | 2013-04-10 |
WO2006124896A2 (en) | 2006-11-23 |
JP2008539989A (en) | 2008-11-20 |
CA2607387C (en) | 2014-12-23 |
AU2006247355A1 (en) | 2006-11-23 |
US8002794B2 (en) | 2011-08-23 |
US20070106246A1 (en) | 2007-05-10 |
US8241325B2 (en) | 2012-08-14 |
WO2006124896A3 (en) | 2007-10-11 |
US20090318889A1 (en) | 2009-12-24 |
EP1885260A4 (en) | 2015-01-21 |
JP5341816B2 (en) | 2013-11-13 |
CN103190942A (en) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8241325B2 (en) | Access and closure device and method | |
US8002791B2 (en) | Access and closure device and method | |
US7678133B2 (en) | Biological tissue closure device and method | |
AU2014208255A1 (en) | Access and closure device and method | |
AU2012200175A1 (en) | Access and closure device and method | |
AU2014203844A1 (en) | Biological tissue closure device and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20170512 |